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ABSTRACT

As a contested illness, breast cancer has mainstream and alternate
narratives that vie to shape related scientific research and legislative policy. The
mainstream breast cancer movement (MBCM) shapes the dominant discourse of
breast cancer risk, prevention, and cure through the utilization of the
conventional biomedical model of knowledge. The environmental breast cancer
movement (EBCM) contests the mainstream breast cancer narrative because
EBCM activists argue that it supports an unequal power dynamic and does not
adequately reflect breast cancer risk and prevention. Through the incorporation
of citizen science and the precautionary principle into breast cancer research and
policy, EBCM activists reframe the mainstream breast cancer narrative. This
thesis illustrates how the EBCM uses citizen science and the precautionary
principle to reframe the risk narrative and the power dynamic found in the MBCM.
Citizen science offers EBCM activists a method to collaborate with the scientific
community and reframe the power dynamic found in the traditional biomedical
model through the inclusion of lay knowledge. The precautionary principle
provides EBCM activists with a model to redefine the role of uncertainty as a call
to action for further scientific research and legislative regulation of toxic
chemicals linked to breast cancer. The research findings demonstrate how
alternate narratives like the EBCM reconstruct the power dynamic found in
dominant illness narratives through the incorporation of public knowledge and the
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involvement of lay activists in scientific research and legislative policy. Phone
interviews, archival materials, and scholarly literature were used in the research
process.
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CHAPTER 1: INTRODUCTION
According to the American Cancer Society, 1 in 8 women in the United
States, or around 12%, will develop breast cancer at some point in their lives
(American Cancer Society 2011a). The mainstream breast cancer movement
(MBCM) uses statistics such the one above to advocate for and fund programs
and scientific research that support mainstream perceptions of breast cancer risk
and cure (King 2006:xix). Mainstream breast cancer advocacy has shaped the
dominant discourse in relation to prevention and cure, as well as making breast
cancer the best funded type of cancer. In 2006, the National Cancer Institute put
over half a billion of its $6 billion cancer research budget towards breast cancer
(New York Times Well Blog 2008). Of all the cancer types funded by the National
Cancer Institute, breast cancer received the most funding per individual with the
disease. Although it is the most funded type of cancer, breast cancer is actually
not the leading cause of death in women. According to the Mayo Clinic, more
women die of heart disease than breast cancer (Mayo Clinic 2011). Despite
significant funding and advocacy, women are still becoming ill with and dying of
breast cancer at a significant rate. There is debate over what causes breast
cancer, as well as how to end the disease. In response to this situation, the
environmental breast cancer movement (EBCM) contests the dominant breast
cancer narrative by reframing mainstream breast cancer research and advocacy.
The research for this thesis was performed in order to understand the
methods that EBCM employs to bring transparency and environmentally
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centered research to breast cancer advocacy. The goal of this thesis will be to
demonstrate how the EBCM contests the dominant or mainstream narrative
through the process of reframing mainstream breast cancer risk and the power
dynamic found in mainstream scientific research and advocacy. This thesis will
start by addressing the contested narrative found in EBCM. It will look at how the
EBCM contests personal risk factors as well as power dynamic in mainstream
breast cancer science. Then it will examine how the EBCM reframes mainstream
breast cancer through lay involvement in breast cancer science and advocacy
that focuses on environmental links to breast cancer. The role of the
precautionary principle in shaping breast cancer research and legislation will be
addressed. I will also analyze the role of scientific uncertainty in shaping
precautionary environmental science and policy. Lastly the role of the lay
community in shaping what aspects of breast cancer are studied, and how they
are studied, as well as in the applications of research findings, will be addressed.
Community programs looking into the racial and socioeconomic ties to the
scientific research process will also be explored. The role of the lay community
in deciding further research and the use of current research findings in local and
national legislation will be analyzed.
Breast cancer is a contested illness because risk and ways to reduce risk
are disputed within the larger breast cancer movement (Ley 2009). Like other
contested illnesses, scientific and social aspects of breast cancer are influenced
by a dominant paradigm (Brown 2007). The dominant paradigm offers the official
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narrative in a contested illness. In response, alternative paradigms contest the
official narrative and assert alternate narratives to explain an illness. Often the
alternative paradigm uses narratives found in the dominant paradigm to reframe
and assert alternative views of the illness.
Contested illnesses that have an alternative paradigm asserting
environmental links to a particular illness have to contend with conventional
scienceʼs inability to definitively prove connections between environmental
causes and risk (Brown 2007). The dominant narrative often uses this inability to
illustrate uncertainty in environmental links to an illness and thus maintain the
authority of the dominant narrative. Contested illnesses such as Mesothelioma
(Brown et al 2000:10) and Asthma (Brown 2007) illustrate how dominant
paradigms often use scientific certainty to undermine the authority of alternative
environmental paradigms that do not operate within the realm of certainty (Button
2010).
In terms of the contestation over breast cancer, the dominant breast
cancer paradigmʼs claim of certainty maintains its position of authority within the
larger illness narrative. The ability to claim certainty is linked to gaining and
maintaining legitimacy in illness narratives. By claiming certainty, the dominant
breast cancer paradigm asserts its legitimacy in the breast cancer narrative and
also uses uncertainty as a way to contest the legitimacy of alternative breast
cancer paradigms. The EBCM uses a public paradigm to contest the dominant
paradigm and its authority within the larger illness narrative (Brown 2007). The
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public paradigm challenges the dominant breast cancer paradigm by advocating
the reduction of breast cancer risk through using precaution in chemical
regulation and advocating for more and better scientific research focused on the
environmental links to breast cancer.
The EBCM contests the dominant narrative of risk that consists of lifestyle,
reproductive, and genetic factors. It also contests the focus on risk management
through the use of technologies such as mammography and pharmaceuticals
such as tamoxifen found in mainstream breast cancer science and advocacy
(Ley 2009). Instead of viewing risk through individual factors like lifestyle,
reproductive health and genetics, the EBCM contests the mainstream narrative
of breast cancer risk by asserting that environmental toxins are associated with a
collective breast cancer risk. The dominant breast cancer narrative focuses on
individual risk because it is easier to argue scientific certainty for individual risk
factors, which are easier to scientifically represent. Since individual risk is the
dominant narrative, it is the “objective frame used by experts and mirrored by the
media” (Button 2010:168). Because the dominant narrative can claim certainty
using individual risk, the dominant paradigm asserts individual risk as the sole
breast cancer narrative. Therefore, the EBCM contests the objective frame of
breast cancer risk asserted by the MBCM. The EBCM also contests the dominant
narrative of technological and pharmaceutical prevention and cure. While the
dominant narrative uses the term “prevention” to refer to preventing late stage
breast cancer and reducing the risk of dying from the disease, the EBCM argues
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that prevention can only occur before a person gets breast cancer. The EBCM
contests the dominant narrativeʼs claim of technological and pharmaceutical
prevention and cure through the assertion that understanding the environmental
links to breast cancer reduces the collective risk.
The EBCM also contests the conventional scientific model which claims
science is expert knowledge, and is more valid than personal experience and lay
knowledge, through the active participation of the lay community in scientific
research (Morello-Frosch et al 2006:249). By prioritizing validity in scientific
knowledge over lay knowledge, the conventional scientific model creates an
uneven power structure between the science and lay community. This uneven
power structure keeps lay knowledge out of the scientific discourse (Button
2010:168). Because lay knowledge is not in scientific discourse, science ends up
perpetuating the dominant discourse related to mainstream views of risk and
cure, while keeping out alternative views of breast cancer risk and prevention.
Since the mainstream breast cancer movement (MBCM) relies on the
conventional scientific model, the EBCM contests the mainstream breast cancer
narrative by developing a “citizenʼs science,” where the lay community is actively
involved in breast cancer research and “become experts in their own
right” (Button 2010:169). An example of citizen science can be found in the Long
Island Breast Cancer Study Project, which later became the Huntington Breast
Cancer Action Coalition. During the Long Island Breast Cancer Study Project,
lay activists collaborated with scientists to determine whether polychlorinated
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biphenyls (PCBs) and organochlorines caused increased cancer rates in local
communities (Brown 2007:79). The project represents how citizen science
includes lay communities in science and scientific decisions related to breast
cancer research. The environmental breast cancer movement (EBCM) contests
the mainstream narrative of breast cancer risk by reconstructing scientific
research related to the public perception of environmental links to breast cancer.
While the EBCM uses the same biomedical knowledge as the MBCM, the main
difference between the two movements are the way they interpret and participate
in scientific research. Drawing largely from the environmental movement, as well
as feminist and social justice movements, the EBCM challenges mainstream
constructions of breast cancer (Ley 2009:12). The EBCM came about as a way
to redefine mainstream constructions of breast cancer and bring awareness to
environmental links to breast cancer. The EBCM redefines the MBCMʼs focuses
on prevention through the technology of mammograms and scientific research
related to finding a medical cure for breast cancer by advocating lay involvement
in science related to finding environmental links to breast cancer (Ley 2009:4).
While mainstream breast cancer advocacy centers around the individual
understanding her own breast cancer risk, the EBCM focuses on assessing
breast cancer risk by looking at how environmental toxins may put communities
at risk for breast cancer.
As a counter movement, the EBCM not only challenges facets of
mainstream constructions of breast cancer causation, but also the social
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structures, like funding, science and political spheres, that influence mainstream
perceptions of breast cancer risk. Environmental breast cancer activists base
their work on the model used by environmental justice groups, which
demonstrates connections between environmental factors and social factors like
gender, race, and class (Baralt 2006:5). The EBCMʼs reframing of mainstream
perceptions and research of breast cancer illustrates that rather than one
“objective” construction of breast cancer as a social problem, there are multiple
collective definitions of the causes of and cures for breast cancer (Blumer
1971:298; Schneider 1985). The key distinctions between the MBCM and the
EBCM are in their perceptions of causal and political responsibility (Gusfield
1984). The EBCMʼs primary goal is to provide women with knowledge of the
potential causes of breast cancer, calling for further testing of causes of breast
cancer, and political involvement in policy and laws that would protect women
from potential and known causes of breast cancer.
The EBCM reframes mainstream discourses of power through the
involvement of lay communities in breast cancer science and legislation. The
goal of lay involvement is creating transparency in the science and legislation
related to breast cancer. The need for scientific and governmental transparency
comes from the “personal is political” framework, which highlights “the political
and economic issues in breast cancer causation, research, and
treatment” (Brown 2007:88). Womenʼs experiences of breast cancer are not just
personal; they are also imbedded in the politics related to the science and
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legislation of breast cancer. The EBCM asserts the claim that since women are
affected by the politics of breast cancer science and legislation, they should be
involved in the decision making process, in order for their perspective to be
incorporated into the science and legislative outcomes (Bogard 2003:212). The
EBCM claims that balancing out the power dynamic through incorporating lay
community members in decisions is the only way that the needs of the lay
community will be adequately addressed. In terms of governmental transparency,
the EBCM promotes collaborating between the lay community and
environmentally focused politicians to create chemical regulatory policy and other
environmental/precautionary principle centered policies. As for scientific
transparency, the EBCM involves the lay community in collaboration with the
scientific community about environmental research related to breast cancer
(Anglin 1997).
The primary way EBCM challenges discourses of power is through the
challenge to the Dominant Epidemiological Paradigm (DEP) and mainstream
science (Brown 2007). The DEP rests authority on the voices of the scientific
community. Conventional science holds that authority in research and results lies
in the scientific or expert community. The EBCM contests the dominant scientific
paradigm by creating a “new public paradigm” which demonstrates that the lay
community, particularly women with breast cancer, have an important perspective
to bring to scientific research related to breast cancer (Benford and Hunt
2003:160; Brown 2007:87-89). In this “community-based participatory research,”
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lay and science communities collaborate to research environmental links to
breast cancer, and to explore the geographic patterns related to breast cancer
risk (Davis 2002:188; (Brown 2007:13). Through collaboration with lay and
science communities, the EBCM hopes to “…broaden scope of what [traditional
science considers] to be environmental problems.” (Brown 2007:87). The EBCM
also works towards a “democratization of science” where there is a public
discourse and involvement in science (Brown 2007:13). Scientific research,
particularly when peer reviewed, is ostensibly democratic because it is reviewed
objectively within the scientific community (Davis 2002:126). However, the EBCM
argues that in reality there are political pressures, such as corporate lobbying,
that drive the design, interpretation, and use of scientific research. The EBCM
wants to change the way science is performed, interpreted and used politically,
as well as future scientific research (Brown 2007:51).
The precautionary principle plays an important role in the EBCMʼs
reframing of science related to breast cancer. According to the precautionary
principle, “the indication of harm, rather than the proof of harm, should be the
trigger for action” (Steingraber 1997:270). The EBCM uses the precautionary
principle to challenge mainstream views that dictate chemicals must be proven to
cause harm before they are regulated by claiming that chemicals should be
regulated until they can be scientifically proven to not cause breast cancer
(Loseke 1999:40). The precautionary principle plays an important role not only in
science, but in legislative advocacy as well. In terms of science, the EBCM uses

9

the precautionary principle to focus scientific research on the environmental
causes of breast cancer. In terms of legislation, the EBCM uses the
precautionary principle to advocate regulating chemicals, like BPA (Karen Miller,
interview, December 2, 2010), that are linked to causing breast cancer.
Central to the precautionary principle model, and the reason it is favored
by the EBCM, is the “concept of uncertainty” (Aven 2006:199). Although links to
environmental toxins and breast cancer risk are apparent, there is still uncertainty
and debate related to what chemicals actually increase breast cancer risk. While
uncertainty is harder to analyze and does not necessarily fit in with scientific
ways of knowing that value certainty, the EBCM claims that the
underdevelopment of knowledge about what chemicals are linked to breast
cancer makes precaution imperative to preserving human life (Button 2010:15).
The EBCM uses the precautionary principle because it “advocates preemptive
action in the face of uncertainty, whether scientific evidence is conclusive or
not” (Mayer et. al 2002:575). The precautionary principle provides the EBCM a
way to demonstrate uncertainty related to breast cancer risk and to advocate for
more regulation of, and scientific research on, chemicals that may cause breast
cancer.
Past literature has discussed the environmental risk factors that the EBCM
links to breast cancer, as well as how lay women have shaped the environmental
discourse. In When Smoke Ran Like Water, Devra Davis (2002:170) writes about
chemicals like DDT and their link to breast cancer. Davis also talks about how
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women affected by breast cancer formed various organizations that have
challenged science and legislation surrounding the disease. In No Family
History: The Environmental Links to Breast Cancer, Sabrina McCormick (2009)
looks into the way the EBCM challenges mainstream ideas about risk related to
family history in order to demonstrate the environmental breast cancer risk.
McCormick also explores how women living in communities affected by high
cancer rates employ “cancer clusters” and collaborate with the scientific
community to demonstrate the link between environment and breast cancer
(2009:90).
In “Mapping out a Search for Environmental Causes of Breast
Cancer” (with Ruthann A. Rudel 2003) and “Environmental Pollutants and Breast
Cancer” (et. al. 2005), Julia Brody looks into the chemicals linked to
environmental risk, as well as the challenges of studying and coming up with
conclusive population based data linking environmental toxins with breast cancer.
In From Pink to Green: Disease Prevention and the Environmental Breast
Cancer Movement, Barbara Ley looks at the how disease kinships, or the social
and biological connections between different diseases, shape how the EBCM
collaborates with scientific community and other disease movements (2009:13).
In “The Social Context of Science: Cancer and the Environment,” Devra Davis
and Pamela Webster (2002) address how social factors like socioeconomic
status and the structure of traditional science affect breast cancer research and
treatment. Davis and Webster promote the use of the precautionary principle
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and the understanding of environmental risk as effective methods to reduce
breast cancer.
The precautionary principle and community involvement in breast cancer
science and advocacy are also addressed in the literature. In “CommunityInitiated Breast Cancer and Environmental Studies and the Precautionary
Principle,” Brody et al (2005) explore studies in Long Island, New York and Cape
Cod, Massachusetts, as well as studies by the National Institute of Environmental
Health Sciences breast cancer and environment centers. They look at how
women activists in all three cases started their own research on the links
between breast cancer and the environment. In “Rethinking Breast Cancer Risk
and the Environment: The Case of the Precautionary Principle,” Davis at al
(2002) look at how scientific research on environmental breast cancer risk can
shape public policy and reduce breast cancer rates. Phil Brown (2007) looks at
how lay communities are reshaping the DEP in order to affect science and policy
that reduces the environmental risk of breast cancer in Toxic Exposures:
Contested Illnesses and the Environmental Health Movement. Throughout “The
Personal Is Scientific, the Scientific Is Political: The Public Paradigm of the
Environmental Breast Cancer Movement,” McCormick (2009) also uses the idea
of the public paradigm to demonstrate how lay communities get involved in the
science and legislation related to the environmental links to breast cancer.
Research on the EBCM has addressed how the movement encourages
lay involvement in science and advocacy, and emphasizes the role of the

12

precautionary principle in the science and regulation of known and potential toxic
chemicals. While past research has looked at the EBCM through the lens of
social movement theory, and some researchers have also looked at contested
narratives, there has been little research that uses social problems theory and
contested narratives to demonstrate how the EBCM contests and reframes the
dominant narrative found in the MBCM. Social problems theory aims at
understanding “the activities of groups making assertions of grievances and
claims with respect to some putative conditions” (Kituse and Spector 1973:415).
Research employing social problems theory and contested narratives is needed
in the EBCM literature because it demonstrates the dynamic social and political
meaning attached to breast cancer science and advocacy. A focus on contested
narratives is needed because they offer a way to demonstrate what the EBCM
argues in order to challenge the dominant narrative of breast cancer risk and the
role of scientific research found in the MBCM. Social problems theory is also
needed because it demonstrates how the EBCM reframes science and advocacy
in relation to the dominant frame found in the MBCM. Social problems theory
provides a way to analyze how the EBCM uses citizen science and the
precautionary principle to contest the dominant narrative found in the MBCM.
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CHAPTER 2: LITERATURE REVIEW
The environmental breast cancer movement (EBCM) demonstrates the
contestation of risk and precautionary measures found within the breast cancer
movement (Brown 2009:229). The EBCM “functions as a ʻculture of
actionʼ...within the broader breast cancer movement” by advocating for a change
in the type of science and the way science is conducted in relation to breast
cancer risk and prevention (Kalawiter 1999; Ley 2009:7). Activists contest the
broader movementʼs focus on individual risk and reliance on conventional
science that does not value lay knowledge. Instead, they argue that breast
cancer affects communities or populations (Ley 2009:8). Looking at
environmental risk factors not only demonstrates community risk but also offers a
way to reduce risk through reducing environmental risk. The EBCM contests the
dominant paradigm through a public paradigm that focuses on citizens actively
engaged in transforming how science looks at breast cancer risk, as well as the
tools it uses to understand and prevent risk.
This chapter will begin by discussing both how the EBCM contests the
mainstream view of risk and how it redefines breast cancer risk based on
environmental factors and social inequalities. Next, this chapter will discuss the
EBCMʼs contestation of conventional scientific narrative in terms of risk
management. The mainstream focus on technology and prevention drugs to
mitigate risk will be discussed. The role of corporations and pharmaceutical
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companies in using and shaping mainstream breast cancer dialogue related to
risk and prevention will also be addressed. Then this chapter will explore how the
precautionary principle is used to redefine risk. The role of uncertainty in
environmental links to breast cancer, and the ways in which the precautionary
principle offers a way to deal with uncertainty will be addressed. Lastly, this
chapter will examine how citizen science uses the precautionary principle to
reshape mainstream dialogues of risk, as well as the way science understands
and prevents breast cancer.

2.1: Risk and Risk Assessment
Perhaps one of the most important factors in preventing breast cancer is
risk assessment, because knowing what factors lead to breast cancer can help
create methods to mitigate or remove the disease (Potts 2000:131; Yadoln 1997).
In the mainstream breast cancer dialogue, understanding and reducing personal
risk factors are key to breast cancer prevention. Personal risk factors, which
include family history and genetics, affect an individualʼs likelihood of developing
breast cancer (Ley 2009:7). The EBCM argues that personal risk factors,
particularly family history, account for only a small portion of women who develop
breast cancer. As a result, the EBCM argues that understanding community risk,
rather than individual risk, is an important part of breast cancer prevention.
Community risk examines how groups of people are affected by toxic chemicals,
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as well as how social inequalities related to race and socioeconomics increase
breast cancer risk.
One personal risk factor the EBCM challenges is family history. It is often
cited by the mainstream as an important risk factor for developing breast cancer
(Bellenir 2009:118). While family history includes potential genetic links, it also
encompasses shared lifestyle risk factors (American Cancer Society 2011b).
Although genetic risk is highly publicized as a major risk factor for developing
breast cancer, the EBCM argues that women with a family history of breast
cancer account for a small portion of women with the disease, and many women
with breast cancer have no family history (McCormick 2009). Women with breast
cancer in their family history only account for 5 to 7 percent of women diagnosed
with breast cancer (Cornell University Program on Breast Cancer and
Environmental Risk Factors in Hew York State 2003:1). While people with a
family history of breast cancer are at a greater risk of developing the disease,
when examining the overall percentage of women with breast cancer genetics
plays a small role in the likelihood of developing the disease.
Furthermore, the EBCM argues that the mainstreamʼs focus on genetic risk
factors like the BRCA1 and BRCA2 genes misses the broader picture of breast
cancer risk. According to the National Cancer Institute at the National Institutes of
Health (2009), BRCA1 and BRCA2 belong to a class of genes known as tumor
suppressors. Mutations of these genes have been linked to the development of
hereditary breast and ovarian cancer. In fact, the National Cancer Instituteʼs
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research shows that “a woman who has inherited a harmful mutation in BRCA1
or BRCA2 is about five times more likely to develop breast cancer than a woman
who does not have such a mutation” (National Cancer Institute at the National
Institutes of Health 2009). Despite the likelihood of a woman with BRCA1 or
BRCA2 developing breast cancer, EBCM asserts that most women do not have
the genetic link to breast cancer. (McCormick 2009:22). In reality, BRCA1 and
BRCA2 account for only about 5 to 10 percent of the total percentage of women
with breast cancer (National Cancer Institute at the National Institutes of Health
2009). As in regard to general family history of breast cancer, the EBCM argues
that breast cancer among those with the BRCA1 and BRCA2 genes is much
higher than those without the faulty genes, while the number of breast cancer
cases linked to the BRCA1 and BRCA2 genes are relatively small.
EBCM activists also argue that women do not experience breast cancer the
same way. Social inequalities related to ethnicity and socioeconomic class put
poor and minority women at greater risk for breast cancer and for later stage
breast cancer because they have less access to quality healthcare than white
women and women of higher socioeconomic status (Zambrana 1988:115-56).
The difference in breast cancer risk among ethnicities and socioeconomic
classes demonstrates the social meaning embedded within the disease and how
this meaning affects risk and risk management (Anglin 1997:1404). Like other
aspects of social inequalities, patterns of breast cancer risk correlate with race/
ethnicity and social class. Often structural issues, elaborated below, create a
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climate in which poor and minority women face more aggressive forms of breast
cancer and, therefore, higher morbidity.
While access to quality health care accounts for white women having a
greater chance of being diagnosed with breast cancer (Ley 2009:139), the lack of
access among minority populations is a major reason why women of color are
more likely to die from the disease. The connection between ethnicity and
diagnosis illustrates the connection between social inequality and access to
healthcare. One reason for the increase in morbidity can be attributed to “lack of
health insurance; lower levels of personal income; and disparities in health care
resulting from racism, classism, and language and other cultural barriers” which
contribute to women of color receiving a late stage diagnosis. The later the stage
in diagnosis, the more likely it is that a person will die from the disease.
Geographic location and occupational risk are also linked to high rates of breast
cancer in minority women (McCormick 2009:76). Asian women provide perhaps
the most compelling example of how changing location can influence breast
cancer risk. Women living in East Asian countries have the lowest breast cancer
rates worldwide, however, when they move to the West, their breast cancer risk
rises to 80 percent for the first generation and their daughtersʼ breast cancer
rates reach those of other women born in the United States (Stellman and Wang
1994).
The EBCM also argues that a womanʼs socioeconomic background affects
breast cancer diagnosis. Poverty is a “powerful predictor of late diagnosis, poor
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treatment, and high mortality” (Hardisty and Leopold 1996:1). Poverty is also
connected to minority womenʼs risk of developing late stage breast cancer and
not receiving adequate treatment because minority women with a late-stage
diagnosis often come from lower socioeconomic brackets. Perhaps more
influential than race or ethnicity alone, socioeconomic status (SES), affects an
individualʼs exposure to toxins in the environment because low economic status
is often linked with lack of “access to education, certain occupations, health
insurance and living conditions...all of which are associated with the risk of
developing and surviving cancer” (Bellenir 2009:82). Economic hardship and
ethnic discrimination increases breast cancer mortality and late stage diagnosis,
due to limited emotional and financial resources available to poor and minority
women (Kasper 2000:183).
According to EBCM activists, corporate and government spheres influence
how social inequalities as well as the environment affects breast cancer. To
understand how this takes place, EBCM activists argue that it is important to
study the structural framework influencing corporate and government spheres.
Although the government is involved in reducing breast cancer through
legislation which increases research and programs that focus on biomedical
prevention and cure, it also encourages corporate support of breast cancer
programs. Instead of attempting to end cancer through understanding potential
origins in industrial chemicals, Sheldon Krimsky argues that “a number of
government officials made the decision that it would be more economically
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beneficial to cure cancer than to prevent it” (McCormick 2009:182). As a result,
the scientific research and prevention programs found in the mainstream
movement reflect the focus on finding a cure for breast cancer.

2.2: Science and Technology in Risk Management
The EBCM contests the risk management and breast cancer
treatment narrative found in the dominant paradigm adopted by the MBCM. The
dominant paradigm guides “biomedical and research centers, government
agencies, health organizations, pharmaceutical companies” and mainstream
advocacy that focuses on prevention through screening measures like self-breast
exams and mammograms, “diagnostic techniques such as surgical and needle
biopsies,” and “treatment modalities such as mastectomies, lumpectomies,
radiation, chemotherapy, and other therapies to remove cancer from the
body” (Ley 2009:4). The dominant paradigm also focuses on understanding
personal risk factors like genetic and reproductive health in order to reduce risk
(Ley 2009:5). EBCM activists contests the dominant model because it places
conventional science above knowledge based on experience of the disease.
Since conventional science is valued more than lay knowledge of breast cancer,
activists also argue that the dominant paradigm does not adequately understand
or reflect the lay communitiesʼ needs in terms of breast cancer prevention and
treatment.
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The EBCM contests the dominant narrative of breast cancer prevention
through a public paradigm that uses public or lay knowledge of breast cancer as
an important component of understanding the disease (Brown et al. 2006).
The EBCM created the public paradigm based on the idea of a “public
hypothesis” in which the public demands to participate in science and scientific
decisions because they want to be part of the decisions affecting their health
(Krimsky 2000; McCormick and Brown 2003). Since the public understands that
scientific decisions influence their lives, they actively participate in science and
critique the conventional science model found in the dominant paradigm through
active collaboration with scientists. Through the public paradigm, lay activists go
“from recipients of expert knowledge to critics of such knowledge” (Ley 2009:6).
By critiquing the conventional science model, the EBCM acts as a boundary
movement. The public paradigm found in the EBCM acts as a boundary
movement because organizations and activists “move between social worlds and
realms of knowledge” though lay and professional collaboration (McCormick and
Brown 2003:547). Moving between lay and scientific spheres, activists are able
to inform science with their personal knowledge of breast cancer while having a
say in medical and scientific decisions that affect their experience of the disease.
One example of EBCMʼs contestation of the dominant paradigm can be
found in the EBCMʼs critique of the conventional focus on prevention through
mammograms. The dominant paradigm asserts that mammograms are essential
to breast cancer prevention because they are able to detect breast cancer before
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it reaches later stages of growth (Davis 2007:270). Embedded in the social and
political narrative of the “war on cancer” (Davis 2007), mammography provides a
way for the dominant paradigm to assert its ability to save lives through
technology. However, the EBCM contests the dominant narrative of
mammography in breast cancer prevention and, similar to their contestation of
personal risk, uses scientific evidence to support their argument that
mammography does not offer true breast cancer prevention. Since it is harder to
detect breast cancer in the dense breast tissue of younger women, the EBCM
argues that mammography is not an effective form of prevention for them (Davis
2007:270). While mammography can detect early stages of breast cancer in
older women, younger women are left out of this form of prevention. The EBCM
also contests the idea that mammography is a good tool for preventing breast
cancer because they argue that if a tumor exists, breast cancer has not been
prevented (Brown 2007:46). The EBCM claims that true prevention exists if you
prevent the tumor before it forms.
Prevention drugs like tamoxifen are another way EBCM claims that
pharmaceutical companies construct breast cancer prevention. Tamoxifen is a
medication that is used to reduce the risk of breast cancer. Tamoxifen is usually
prescribed as a preventative measure for women with a high risk of breast
cancer, particularly if they test positive for BRCA1 or BRCA2 (National Human
Genome Research Institute 2011). Despite the use of tamoxifen to decrease
breast cancer risk, the EBCM uses conventional scientific research to argue that

22

in some cases it can actually increase the risk of other cancers (Ley 2009:94).
The EBCM turns to research from organizations like the National Cancer Institute
at the National Institutes of Health (2008) to illustrate that tamoxifen can increase
risk of blood clots, stroke, and endometrial cancer and uterine sarcoma. If a
person is at an increased risk for cancer, due to genetic or environmental causes,
taking tamoxifen could increase their risk of getting other types of cancers. The
EBCM argues that prevention pills like tamoxifen are not an adequate form of
prevention because they can actually put women at risk for developing other
diseases (A1). Although the EBCM differs from the MBCM in its approach to
mitigating risk, both movements use conventional biomedical knowledge to
support their claims.
Looking at the role of the pharmaceutical industry, particularly in the area of
organizational funding and government lobbying, illustrates the EBCMʼs claim
that the dominant narrative focuses on prevention rather than finding the cause
of breast cancer. The focus on medication and medical breast cancer prevention
has a clear connection to pharmaceutical companies like AstraZeneca, the
manufacturer of tamoxifen (Ley 2009:39). The role of AstraZeneca in shaping the
dominant narrative of breast cancer prevention can be seen in their creation of
Breast Cancer Awareness Month. The National Breast Cancer Month (NBAM)
was founded in 1985 by Zeneca (now AstraZeneca), a multinational
pharmaceutical corporation and then-subsidiary of Imperial Chemical Industries
(Brown 2007:86). Breast Cancer Awareness Month shapes the dominant breast

23

cancer narrative because it focuses on technological prevention through
mammograms (Brown 2007:44). NBAM helps generate awareness and funding
for mainstream breast cancer programs that support the dominant narrative of
technological prevention. The EBCM claims that pharmaceutical companies
focus on medical and technological prevention rather than understanding the
causes of breast cancer because they can make a larger profit from
mammograms and prevention pharmaceuticals than curing breast cancer (Ley
2009). Pharmaceutical companies use lobbying as well as donations to fund
organizations and support legislation that correlate with their agenda of
prevention through mammograms and prevention pharmaceuticals.

2.3: The Precautionary Principle
EBCM activists base their pubic paradigm on the precautionary principle,
which places the burden of proof regarding the health effects of chemicals on the
producers rather than the consumers and declares that proof of safety should
exist before chemicals are utilized (McCormick et al. 2003:546; Raffensperger
and Tickner 1999):
In order to do this, the environmental breast cancer movement works
toward four goals: (1) to broaden public awareness of potential
environmental causes of breast cancer; (2) to increase research into
environmental causes of breast cancer; (3) to create policy that could
prevent environmental causes of breast cancer; and (4) to increase
activist participation in research.
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Since the precautionary principle challenges traditional scienceʼs need for
certainty, the concept of uncertainty is an important part of the precautionary
principle. Through the precautionary principle, activists challenge the dominant
scientific paradigm’s claim that chemicals must be proven to cause harm before
they can be regulated. EBCM activists argue that “tens of thousands of
chemicals already on the market, and dozens more are developed every year” all
without scientific proof of their safety (Ley 2009:82). Proving whether or not all
these chemicals are safe could take years, and science is also limited in what it
can prove. Because of the time and scientific restrictions, activists turn to the
precautionary principle to advocate for chemical regulations. Their argument
rests on the idea that proof of harm should not come after people are already
affected by toxic chemicals. Regulating chemicals should occur until science can
prove that certain chemicals are safe for the public. Although there are scientific
challenges to proving the connections between toxins and breast cancer,
activists argue that there is enough research to be able to show a link and to
prevent disease through regulation (Ley 2009:82). Activists use the
precautionary principle to not only demand that science focus more on
environmental causes of breast cancer, but also to advocate for a better scientific
framework and better scientific methods. Since the precautionary principle acts
more as a “conceptual framework...it can be implemented to meet the specific
needs of the particular problem at hand” (Ley 2009:88).
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The precautionary principle does not get much attention in the United
States, mostly because the concept of regulation without exhaustive testing and
viable alternatives does not really exist. Current U.S. chemical regulations
require substantial evidence of harm before regulatory action is taken, regardless
of the availability of alternatives (Brody et al 2005:921). Since corporate
involvement is prevalent in government legislation and regulation laws, methods
like the precautionary principle are not in line with a legal system that is generally
conservative when it comes to change. In order to include the precautionary
principle in the legislation, activists must try to change the legislative process,
particularly in terms of corporate lobbying. EBCM activists argue that corporate
lobbyists, especially trade associations, have “a disproportionate influence in the
regulatory process” (Davis and Webster 2002:25). Not only do trade
organizations have millions of dollars to use in lobbying efforts, but they also
have the ability to hire scientists that generate uncertainty related to toxic
chemicals and use this information to help them lobby against regulation of
chemicals (Davis and Webster 2002:25). The uncertainty created by scientists
hired by trade organizations not only influences legislation through lobbying, but
it also effects how the general public perceives the role of toxic chemicals in
breast cancer risk. The EBCM argues that generating uncertainty illustrates the
power placed on certainty in the dominant framework. In order for environmental
risk to have a place in scientific research and legislation, the EBCM challenges
the dominant scientific framework through contesting scientific certainty.
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The EBCM uses the precautionary principle to illustrate the power in the
claim of scientific certainty found in the dominant science and social frameworks.
Focusing on individual risk factors (Davis et al 1998) and risk management
through technology and pharmaceuticals allows the dominant scientific
framework to claim certainty because individual risk and prevention technologies
like mammograms are easier to scientifically demonstrate than community risk
and prevention techniques. The power science places on certainty and the
ability to gain more certainty from looking at risk and risk management at an
individual level allows the dominant framework to exist in a position of power.
Since looking at risk at a community level does not offer the same level of
certainty, EBCM activists do not have authority and power in conventional
science. Through the use of the precautionary principle, the EBCM challenges
the dominant framework that emphasizes certainty, while at the same time
working with science to create better research and research methods. Since
communities are at risk and have knowledge related to their experience with
breast cancer, EBCM argues that communities should challenge the dominant
framework. Community experiences and knowledge offer a way to contest the
certainty asserted by the dominant paradigm. Although the dominant scientific
framework maintains power through the assertion of certainty, the EBCM
contests this power by focusing on citizen science and collaborating with
scientists to change the research process (Brody et. al. 2005).
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2.4: Citizen Science
In order to contest the dominant epidemiological paradigm that influences
narratives about mainstream breast cancer risk and prevention, the EBCM uses
citizen science to actively work with the scientific community. Citizen science
consists of “lay-professional collaborations in which citizens and scientists work
together on issues identified by laypeople” (Brown 2007:33). The precautionary
principle is an integral part of citizen science because it fosters public
participation and understanding of environmental breast cancer risk (Brody
et. al. 2006). Through the employment of the precautionary principle, citizen
science challenges conventional science to prove the safety of chemicals before
they are used in public products. Citizen scientists are lay individuals who
collaborate with the scientific community on scientific research. Although they
are not scientific experts, collaborating with the scientific community gives citizen
scientists the scientific legitimacy in scientific and legislative communities.
Environmental breast cancer organizations often bring the lay and scientific
communities together in research process. Citizen scientists actively participate
with conventional scientists to define what should be researched, how it should
be researched, and how to use research findings to affect local and national
legislation (Brown 2007).
According to the citizen science model, lay observations are key to
understanding the environmental factors that are linked to breast cancer risk
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(Brown 2007:50). The citizen science model is about “interjecting lay knowledge
into traditional scientific ways of generating explanations” (Brown 2007:71).
Since the lay community is affected by environmental factors, their perspective
allows science to more adequately reflect the needs of communities at risk. A
fundamental focus of the EBCM is on the ways in which breast cancer impacts a
womanʼs understanding of her body, and how this knowledge can inform breast
cancer research. Through collaboration with the scientific community, citizen
science counteracts the “inadequacy of the patriarchal medical profession to
understand a breast cancer illness experience that is deeply rooted in being a
woman” (Morello-Frosch et al 2006:258). Citizen science allows activists to
regain power over lay bodies that are directly affected by breast cancer, and use
lay experience with breast cancer to inform research. Unlike individual risk
factors, looking at environmental risk demonstrates how populations are at risk
because environmental toxins affect risk at a community level (Ley 2009:8). By
looking at environmental risk, citizen science also places importance upon
understanding community risk rather than individual risk.
An example of how citizen science looks at community risk is through
mapping breast cancer clusters (DaiKwon 2004). Long Island activists in Suffolk
County noticed that there were a number of women who had breast cancer in
their area. Through mapping the location of women with breast cancer, the
activists were able to see a pattern that suggested a connection between women
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with breast cancer and living near water contaminated by pesticides (Ley
2009:59). Cancer clusters like the one in Suffolk County to demonstrate a
pattern in breast cancer causation. Illustrating a pattern in risk connects
individual women together to illustrate that they share environmental risk at the
community level. EBCM activists claim that elevated breast cancer rates found
in cancer clusters also fit into “part of a larger international puzzle about patterns
of breast cancer incidence and mortality” (Brody et al 1996:497). Understanding
cancer clusters and the chemicals that cause them offer science a way to
understand how environmental toxins effect breast cancer risk. Much like the
example of Suffolk county, women in the community are the ones who bring the
issue of high breast cancer rates to the attention of local government and
scientific communities. With support of politicians like New York Republican
Senator Al DʼAmato and research organizations like the National Cancer Institute
and the National Institute of Environmental Health Sciences, the women of
Suffolk county long island were able to get Public Law 103-43 passed
(McCormick 2009:93). The law mandated research into the possible
environmental factors linked to breast cancer in their area. The case in Suffolk
county illustrates how the lay community reaches out and is able to garner
support from political and scientific communities to understand cancer clusters.
The example of cancer clusters also represents the importance the lay
community places on conventional science to understand the environmental links
to breast cancer.
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Citizen science influences scientific decisions through representation on
advisory boards. Advisory boards offer lay activists a way to engage with
scientists as part of a research team (Brown 2007:146). Through engaging with
scientists, activists have transparency and influence on the decisions that
are made. An example of citizen science representation on advisory boards can
be seen in the founding of the Silent Spring Institute. Originally the Cape Cod
Breast Cancer and the Environment Study, the Massachusetts Breast Cancer
Coalition (MBCC) used state granted money to form the Silent Spring Institute
(Brody 2005:921). As in Long Island, residents in Cape Cod noticed increased
rates of breast cancer in their community, and through mapping the clusters they
were able to get a legislative mandate in order to fund further research on the
causes of the high rates of breast cancer in their community. The Silent Spring
Institute was created by the MBCC as a way to “transcend ‘science as usual’ and
[give] activists governance roles on the scientific team” (Brody 2005:921).
Advisory boards, like the one created by the Silent Spring Institute, demonstrate
the EBCM’s goal in bringing transparency to the scientific process by
incorporating the lay community in scientific decisions related to breast cancer
research.
The key component of citizen science is to increase transparency in the
scientific process through a “democratization of science” (Brown 2007).
Increasing transparency in the scientific process means that lay activists are
actively involved in science and scientific decisions related to breast cancer
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research. While experts within the dominant scientific paradigm are not generally
receptive to lay involvement in science, there are a growing number of scientists
who engage in critical epidemiology. In the context of citizen science, critical
epidemiologists combine their expert knowledge with social justice issues
through collaboration with the lay community in the scientific process (Brown
2007:37). Along with critical epidemiologists, citizen science contests power
placed on expert knowledge in the dominant scientific paradigm by placing value
on lay knowledge. Collaborating with scientists and having positions of power in
the scientific process allows lay knowledge to permeate and change the scientific
process. The research problems that are studied and the methods used to study
these problems are colored by lay knowledge and experience with breast cancer.
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CHAPTER 3: METHODOLOGY

3.1 Methods
Archival research was analyzed and consisted of electronic documents,
journals, books, and websites. Web based materials from The
Collaborative on Health and the Environment’s Breast Cancer Working Group
(CHE) were used. A podcast of CHE’s conference call entitled, “Breast Cancer
and the Environment: A Life Course Approach: A New Report from the IOM,”
which took place on December 16, 2011, was also used. In addition to archival
research, interviews were conducted. Interviews took place during November
and December of 2010 by telephone. Participants located in the East Tennessee
area were originally sought, but due to lack of environmental organizations in
the area, participants could not be found. However, participants from
New England and California were found through internet research. Due to
distance restrictions, phone interviews were used. Participants were chosen
based on their involvement in various non- pink breast cancer organizations.
Since these organizations challenge mainstream views that are associated with
pink ribbon campaigns, they are non-pink organizations. Although most focus on
environmental causes related to breast cancer, not all organizations chosen
solely focused on environmental links to breast cancer. Participating
organizations had varied ideas related to environmental causes of breast cancer,
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collaboration with mainstream breast cancer groups and funding policies.
Although they varied in their policies and advocacy, they all shared a mission to
challenge mainstream views of breast cancer advocacy.

3.2 Challenges
There were numerous challenges in completing this research. The most
significant challenge to the research was the number and size of the
organizations sought for the study. Since there was a small number of non-pink
organizations and each organization had a small staff, the number of individuals
available for interviews were limited. The organizations that participated were
not mainstream breast cancer organizations. Non-pink organizations, particularly
those that focus on environmental causes of breast cancer, generally have a
small staff and there are only half a dozen or so (A2) that can be found online.
Interviewees also mentioned that the environmental breast cancer movement is
small. Geographic location was also a challenge because most non-pink
organizations were located either in California or in the northern region of the
United States.
Six e-mails were sent to individuals working on public outreach in Silent
Spring Institute, Breast Cancer Fund, National Breast Cancer Coalition, Breast
Cancer Action, and Zero Breast Cancer asking for their participation in the study.
A brief description of research goals and benefits were included in the e-mail.
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After the six e-mails were sent out and phone calls were made to all the
individuals e-mailed, interviewees were selected based on responses to either
form of contact. One individual from Breast Cancer Fund, two individuals from
National Breast Cancer Coalition and one individual from Breast Cancer Action
were interviewed. Each phone interview lasted for roughly an hour. Topics of
discussion included the organization’s history, collaboration with other cancer
organizations, advocacy for connecting social disparities to breast cancer risk,
legislative advocacy, scientific collaboration, as well as policies related to
funding. The interviews were concluded with final thoughts from the interviewees
and information related to any other individuals who would like to
participate in the study. The real names of participants and organizations were
maintained throughout the research process.
While the use of phone interviews provided a way to conduct research
with organizations outside the Knoxville area, there were limits to this mode of
research. Unlike methods such as participant observation, where the researcher
can actively engage with the interviewee, the use of phone interviews limited the
time spent with the each person who participated in the research process. Also,
this type of research limited the ability to create rapport, not only by limiting the
time spent with the interviewee, but also because the interviewee never saw the
interviewer in person. The lack of contact inhibited the ability to pick up on facial
and body language cues related to the interview process. Although the use of
Skype or other video conference software could have aided in the ability to build
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rapport, it could not be used because the individuals that participated in
interviews did not have access to that type of technology.
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CHAPTER 4: RESULTS

4.1 Risk
The EBCM contests individual risk factors that are advocated in
mainstream prevention. Through the contestation of individual risk supported by
the MBCM, the EBCM seeks to redefine scientific research related to breast
cancer (Hilgartner and Bosk 1988: 55). According the EBCM, the overall
percentage of women who have individual risk factors like family history or
reproductive history is low in comparison to the overall percentage of women with
breast cancer. Miriam Hidalgo (interview, November 30, 2010) from Breast
Cancer Action asserts that risk factors related to breast cancer “are present only
in 30 percent of women” and “70 percent are causes that we are not aware of.”
Instead of focusing on the smaller percentage of women with individual risk
factors, science should look at “what exposures are linked to environmental risk
that are leading to the disease” (Miram Hidalgo, interview, November 30, 2010).
Breast Cancer Action views breast cancer as a “complex group of diseases that
occurs in an environmentally complex world” (Breast Cancer Action 2011a).
Many different chemicals are involved in breast cancer risk. As a result of this
complexity, the EBCM claims that new ways of doing science must occur to
understand how different chemicals interact with the body to increase breast
cancer risk (Benford and Hunt 2003: 154).
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By contesting individual risk factors, the EBCM argues that family history
plays a small role in breast cancer risk. In contrast, MBCM activists argue that
family history increases a womanʼs risk of developing the disease. According to
the American Cancer Society, “breast cancer risk is higher among women whose
close blood relatives have this disease,” and “having one first-degree relative
(mother, sister, or daughter) with breast cancer approximately doubles a woman's
risk” for developing breast cancer (American Cancer Society 2011). Despite
mainstream activistsʼ assertion that family history drastically increases the risk of
developing breast cancer, environmental activists argue that family history only
represents a small portion of women who get breast cancer. The National Breast
Cancer Coalition (NBCC) claims that while “the risk for developing breast cancer
does increase with increasing numbers of affected first-degree relatives
compared with women who have no affected relatives,” most women with family
history “will never get breast cancer” (National Breast Cancer Coalition 2011b).
Although family history is a significant risk factor for some women, when looking
at individuals with breast cancer as a whole, family history only represents a
small demographic of women. The case of family history illustrates how the
EBCM and MBCM both use scientific studies of breast cancer risk but draw
different conclusions from the research. The NBCC also asserts that family
history, while advocated by the mainstream breast cancer movement as a major
risk factor, is only one risk factor among many potential risk factors for breast
cancer. The contestation of family history is used by the NBCC to illustrate that
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“a risk factor doesn't cause cancer, it just affects your chance of getting
cancer” (National Breast Cancer Coalition 2011b). Women who have family
history do not always get breast cancer, while there are a large number of
women with no family history that do develop the disease. The EBCM asserts
that risk is a larger and more complex picture than personal risk factors like
family history. The key to understanding complexity is through researching the
environmental links to breast cancer.
Similar to family history, the EBCM asserts that genetic links like BRCA1
and BRCA2 are only a small part of a larger picture of breast cancer risk.
Mainstream breast cancer activists argue that women with the BRCA1 and
BRCA2 genetic mutations are more likely to get breast cancer. Because of this
assertion, mainstream activists focus their efforts on educating women about
BRCA1 and BRCA2. Mainstream activists also encourage women to get tested
as a preventive measure. According to A.D.A.M. Medical Encyclopedia, BRCA1
and BRCA2 genetic mutations increase breast cancer risk and “women with one
of these defects have up to an 80% chance of getting breast cancer sometime
during their life” (PubMed Health 2011). However, environmental breast cancer
activists view the mainstreamʼs focus on BRCA1 and BRCA2 testing as an
example of how the mainstream misses the broader issue of breast cancer risk
because the mutation only exists in a small number of women who develop the
disease. The EBCM advocates for women to educate themselves about the
research on BRCA1 and BRCA2 before deciding whether or not to receive the
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genetic test (Breast Cancer Action 2012b). While the EBCM focuses on
restructuring risk assessment away from a focus on biomedical methods like
BRCA1 and BRCA2 testing, they also seek to empower women with the science
associated with biomedical prevention so they can make their own decisions
about prevention options. Rather than contesting the validity of genetic testing,
The EBCM is actually contests the mainstream interpretation of the tests and
their effect on how women view their own breast cancer risk. The EBCM argues
that there is still an unknown factor that causes some women with the mutations
to get breast cancer and some to never get the disease. Through the
understanding of the complex environmental factors associated with risk, the
EBCM claims that the scientific community can better understand how risk
factors play out in cancer rates.
In order to understand the complex nature of risk, the EBCM focuses on
how multiple risk factors, particularly environmental toxins, interplay to affect risk
at a population or community level. The Breast Cancer Fund asserts that looking
at “exposures to radiation, carcinogens, and chemicals that act like hormones
(known as endocrine disruptors)” illustrate “the complex web of breast cancer
causation” (Breast Cancer Fund 2011a). According to the Breast Cancer Fundʼs
biennial report, “State of the Evidence,” activists not only look at the ways various
risk factors interact with each other to increase overall risk but they also assert
that women often are not aware of all the toxins they are exposed to (Gray et al
2010:11). For example, the biennial report argues that:
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We focus on peopleʼs exposures to environmental chemicals, including
many of those found in personal care products, household products,
plastics, food, air and water, as well as several sources of radiation,
including medical radiation and electromagnetic waves. Although we
may have control over our personal use of some of these chemicals,
exposures to many of these factors are not voluntary. On a daily basis,
we are all exposed to many of these agents in the air we breathe, the
water we drink, the grounds we walk and play on, the toys and other
products we handle, and the substances we put on our bodies. Often
we are not even aware of these exposures.
Through scientific research into the role different chemicals play in breast cancer
risk, and through making this information accessible to the public, the EBCM
asserts that breast cancer risk can be reduced. Understanding the role
chemicals play at a population level is also an important part of the NBCCʼs
research and advocacy because population level risk helps to “determine which
factors increase breast cancer risk and how much increase in risk is caused by
each factor” (National Breast Cancer Coalition 2011a).
The EBCM also explores how the link between social inequalities and
breast cancer risk influence community risk. Mainstream organizations focus on
risk factors like genetics that not only focus on individual risk but also view risk
factors as evenly represented in the data for breast cancer risk. According to
Living Beyond Breast Cancer, “what all people with breast cancer have in
common are ʻbad copies,ʼ or mutations, in the DNA of their breast cells” (Living
Beyond Breast Cancer 2010). While the mainstream breast cancer movement
focuses on the commonality of individual risk factors like genetics, environmental
breast cancer activists focus on how social disparities put ethnic minorities and

41

poor populations at an unequal rate of risk and mortality compared to other
populations. Disparities among ethic minorities, particularly in terms of access to
care, illustrate how the social context that minorities live in influences their risk of
developing breast cancer. Since white women are more likely to have access to
quality health care as opposed to minority populations, it can also be inferred that
white women have higher rates of diagnosis (National Cancer Institute at the
National Institutes of Health 2008b) because they are more likely to go to get
preventative screening and detect breast cancer earlier than minority women.
Both the care of higher rates of diagnosis among white women and the high rate
of minorities dying form the disease illustrate how access to healthcare is crucial
to diagnosis and preventing women from dying of breast cancer. Marisa Walker
from the Breast Cancer Fund mentions that “huge disparities in terms of care
have complex factors particularly around African American women and breast
cancer” (interview, December 10, 2010). Organizations like the Breast Cancer
Fund often collaborate with outside research studies, like the University of
Pittsburgh (Marisa Walker, interview, December 10, 2010), to understand how
access to care affects risk in order to develop advocacy that can help women
reduce their risk of breast cancer.
The EBCM also uses migration studies to illustrate how breast cancer risk
is related to geography and, more importantly, what kinds and concentrations of
chemicals are located in different geographic areas. Individuals from more
industrialized countries, such as the United States, have a much higher rate of
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breast cancer than individuals from less industrialized countries (Breast Cancer
Action 2008a). The EBCM makes the geographic connection even more
pronounced by demonstrating that when individuals move from a nonindustrialized to a more industrialized country, their breast cancer risk increases.
The Breast Cancer Fundʼs “State of the Evidence” report uses breast cancer
rates among Hispanic women to demonstrate that while immigrant Hispanic
women have lower rates of breast cancer than “Hispanic women born in the
United States,....the longer the period of time these Hispanic women spend in the
United States, the greater their risk for breast cancer” (Gray et al 2010:14).
Although there are multiple reasons for the disparity among ethnic
minorities and women of lower socioeconomic status in the United States, the
Breast Cancer Fund claims, “ it is clear that poverty is linked to greater chemical
exposure and, thus, greater risk” (Breast Cancer Fund 2011b). While white and
more affluent women are more likely to live in areas that have less exposure to
chemical toxins and have access to quality healthcare, poor and minority women
are less likely to have access to these factors and are therefore more likely to
have a greater risk of developing late stage and more aggressive forms of breast
cancer. Access to quality housing and healthcare are linked to social inequalities
and illustrate how social disparities influence breast cancer risk. Poorer women
not only have limited access to health care, which puts them at greater risk for
developing late stage breast cancer, but they are also more likely to live near
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areas that are polluted and thus increasing their risk of exposure to
environmental toxins (Breast Cancer Fund 2011c).
Instead, these communities are situated near factories, waste-disposal
sites, agricultural areas or other sources that constantly or regularly spew
toxic chemicals or radiation into the environment. Some of these sources
are recorded by the Environmental Protection Agency's Toxic Release
Inventory (TRI) database. In many cases, sources of pollution are
clustered in a small area, meaning that communities near one TRI site are
often near several other pollution sources. Research suggests that
mixtures of chemicals may multiply risk. In addition, TRI facilities are more
likely to be located near communities with higher proportions of people of
color and people with lower socioeconomic status.
The potential exposure to multiple types of toxins resonates with environmental
advocacy because they argue that exposure to multiple toxins increases breast
cancer risk, and that science still does not have adequate ways to test how
multiple toxins interplay with each other to increase risk. The Breast Cancer
Fundʼs discussion of communities located near polluted areas also demonstrates
how ethnicity and socioeconomic status are interlinked in exposure to
environmental toxins The EBCM uses science and data on social inequalities to
contest the mainstream movementʼs focus on individual risk factors (Spector and
Kitsuse 1973: 146). Through understanding how multiple chemicals affect risk on
a population level and how social inequalities affect risk, the EBCM seeks to
reduce the number of women who get breast cancer.
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4.2: Science and Risk Management
Along with contesting dominant views of breast cancer risk, the EBCM
also contests the science related to methods used to manage breast cancer risk.
Breast Cancer Action (BCA) calls into question the effectiveness of medical
prevention and advocates for prevention that focuses on the environmental
causes of breast cancer (Breast Cancer Fund 2007). Breast Cancer Action
argues that younger women are getting breast cancer at an increasing rate and
prevention strategies supported by the dominant science community are not only
failing to prevent overall breast cancer risk but they are also failing to prevent
younger women from getting the disease (Breast Cancer Action 2007; Bash
1995:3). The EBCM examines risk in non-traditional at-risk groups like younger
women to illustrate that dominant science is not effectively preventing breast
cancer. The EBCM focuses on lay involvement in science and legislation in
order to change the MBCMʼs focus on medical prevention to a type of prevention
that examines the environmental links to breast cancer. The EBCM also
challenges the role of corporate sponsorship in funding and influencing dominant
science and lobbying.
In order to challenge dominant prevention and lobbying efforts, the EBCM
not only calls for lay involvement in breast cancer research but activists also work
for lay involvement in breast cancer legislation as well. According to Karen Miller,
“Diseases are politically driven. The things that prevent us from achieving our
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successes are political. The things that enable us to achieve our successes are
political” (Karen Miller, interview, December 2, 2010). EBCM activists argue that
they must also be involved in the legislative process that dictates dominant
science and prevention, as well as chemical regulation. The EBCM must also
contend with corporate lobbying efforts to further the corporate agenda by
focusing on medical prevention while undermining the regulation of chemicals
linked to breast cancer risk.
The EBCM contests the mainstream focus on medical prevention through
mammograms by arguing that mammograms are not reliable and they do not
truly prevent breast cancer. Mainstream breast cancer organizations advocate
mammography as an effective way to prevent late stage breast cancer, thereby
decreasing the risk that a woman will die from the disease. Komen for the Cure
argues for “the life-saving benefits of mammography” and that “mammography is
the most effective breast cancer screening tool used” for early detection (Susan
G. Komen for the Cure 2012a). Environmental breast cancer activists contest
the effectiveness of mammography in their claim that it is not as accurate as
mainstream activists claim, and they point out the fact that it only finds breast
cancer once it is already formed. According to the NBCC, false positives actually
put women in more danger because they “may lead to unnecessary, intrusive
surgical interventions, while false negative results will not find cancerous
tumors” (National Breast Cancer Coalition 2011c). The NBCC also claims that
the more mammograms a woman has, the more likely she is to have a false
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positive, which increases her chance of having an unnecessary invasive
procedure like a biopsy. Instead of focusing research and pubic attention on
mammography, the EBCM argues that “resources must be devoted to finding
effective preventions and treatments for breast cancer and tools that truly detect
breast cancer at a time where an intervention will help” (National Breast Cancer
Coalition 2011d).
The EBCM also contests mainstream prevention through pharmaceutical
drugs like tamoxifen, again arguing that they are not only an inadequate form of
prevention, but they also have the potential to harm women and take resources
away from finding environmental links to breast cancer. Mainstream breast
cancer advocacy argues that prevention drugs like tamoxifen are an effective
way to prevent breast cancer in women who are at an increased risk of
developing the disease. The National Cancer Instituteʼs information on tamoxifen
demonstrates how it is used prevent breast cancer from forming again or growing
(National Cancer Institute at the National Institutes of Health 2008a):
As adjuvant therapy (treatment given after the primary treatment to
increase the chances of a cure), tamoxifen helps prevent the original
breast cancer from returning and also helps prevent the development of
new cancers in the other breast. As treatment for metastatic breast cancer,
the drug slows or stops the growth of cancer cells that are present in the
body.
In contrast to this position, environmental breast cancer activists argue
that drugs like tamoxifen have side effects that put women at risk for other health
issues, and their use distracts breast cancer advocacy from focusing on
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prevention. EBCM organizations like Breast Cancer Action advocate to inform
the public about drugs to prevent breast cancer. In their Policy on Pills for
Prevention, the BCA gives information about drugs like tamoxifen and raloxifene,
as well as Aromatase Inhibitors (Breast Cancer Action 2011b). In all of the
examples of drugs and other medical treatments to prevent breast cancer, BCA
argues that there is insufficient high quality research to support the MBCMʼs
claims about effectiveness . BCA uses research from the scientific community
(Breast Cancer Action 2011b) to illustrate the numerous risks associated with
medical treatments to prevent breast cancer. While EBCM organizations
challenge biomedical treatments supported by the MBCM, the EBCM still uses
scientific research to back up their claims. Informing the public about the effects
of drugs for preventing breast cancer and the effects of drugs on understanding
environmental links to breast cancer is at the core of BCAʼs prevention policy
(Breast Cancer Action 2011b):
Women deserve to be fully informed about the benefits and risks of breast
cancer “prevention” drugs prior to making a decision about whether or not
to take them. At present, individuals are making decisions under
conditions of uncertainty. Breast Cancer Action, while clearly
understanding the large numbers of women at risk for developing breast
cancer, does not advocate using drugs to treat risk. It is difficult to imagine
a drug powerful enough to actually reduce the risk of breast cancer that
will not have serious side effects. Moreover, the focus on pills for
prevention of disease diverts resources from finding and eradicating
environmental causes of, as well as effective treatments for, breast cancer.
While environmental breast cancer advocates illustrate the potential harm that
biomedical treatments like tamoxifen can have on the body, their argument about
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mainstream prevention highlights the unequal attention given to environmental
causes of breast cancer. Although there is significant funding for breast cancer,
most of these funds go towards research for biomedical prevention and
treatment. EBCM activists argue that instead of focusing prevention on
pharmaceutical drugs like tamoxifen prevention resources should go to
researching environmental factors that are leading to breast cancer and finding
ways to reduce those risk factors.
In order to challenge dominant science and the corporate agenda, the
EBCM lobbies to remove environmental toxins from environment, particularly in
household and personal care items. The Breast Cancer Fund is an example of
an EBCM organization that focuses their advocacy on legislation in order to
eliminate chemicals linked to breast cancer. A primary way the BCF focuses their
legislative efforts is through the Campaign for Safe Cosmetics, which seeks to
remove toxic chemicals from personal care products. The Campaign for Safe
Cosmetics was created by the BCF in 2004 as “a coalition of environmental
health and womenʼs organizations working in partnership to get toxic chemicals
out of personal care products which includes everything from shampoo, lipstick,
soap, menʼs products, womenʼs products and baby products” (Marisa Walker,
interview, December 10, 2010). The campaign started as a way to hold
corporations responsible for the chemicals they put in their products. By 2010,
the campaign transitioned into working with federal legislation regarding safe
products. Inspired by legislation passed in 2004 by the European Union for safer
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cosmetics in Europe, the BCF wanted to bring similar legislation to the United
States. In July of 2010, the Safe Cosmetics Act was introduced by Dan Jakowski
in the House of Representatives. According to Marisa Walker (interview,
December 10, 2010), the goal of the Campaign for Safe Cosmetics is to create a
baseline of safety for all consumers:
We donʼt want to be in a situation where the educated wealthy consumers
are the oneʼs who can find the safe products while the person who shops
at a dollar store or who doesnʼt have time to research safe cosmetic
ingredients is not getting a safe product. It is really meant to establish a
baseline of safety for everyone and to remove the most harmful
ingredients that cause cancer and reproductive harm from the products.
The BCF also worked on the Ban Poisonous Additives Act, “which was a
ban on BPA in food cans, serving dishes, bottles and packaging” (Marisa Walker,
interview, December 10, 2010). The legislation later became an amendment
Senator Feinstein offered to the Food Safety and Modernization Act. It was
blocked in late 2010 by the American Chemistry Council. The blocking of the
Food Safety and Modernization Act by the American Chemistry Council
demonstrates how the EBCM must contend with the influence of dominant
science in the legislative process. The blocking of this legislation illustrates how
lobbying keeps the dominant science agenda on top. This demonstrates that
contesting dominant science through the legislative process is a constant battle,
despite growing scientific evidence of harmful effects of toxic chemicals like BPA
(A3).
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The EBCM contests the role of corporate funding in shaping the public
perception of risk management, and in shaping agendas for the funding of and
legislation related to breast cancer prevention. Corporate sponsorship is often a
major source of funding for mainstream breast cancer organizations. The
National Breast Cancer Foundation states that “each of our corporate
sponsorships is critical in furthering and strengthening our mission to gain the
advantage over breast cancer” and that, “the initiatives they have helped us
implement have been lifesaving to thousands of women” (National Breast Cancer
Foundation, INC. 2012a). Partners for the National Breast Cancer Foundation
include MagLite Flashlights, Proctor and Gamble as well as Reynolds (National
Breast Cancer Foundation, INC. 2012b). Mainstream organizations like the
National Breast Cancer Foundation view corporate funding as a vital opportunity
to reach more women with their advocacy.
On the other hand, environmental breast cancer advocates view corporate
funding as a way for corporations to manipulate the message of risk and
prevention. On the topic of funding, Miram Hidalgo (interview, November 30,
2010) mentioned that Breast Cancer Action does not “receive funding from
corporations. That really helps our transparency. It helps us really to be able to
give unbiased messages about treatment options and about whatʼs really going
on with the cancer movement.” The EBCM argues that accepting funding from
corporations can create biased advocacy because corporations often have
stipulations that come with their funds. These stipulations often focus funds on
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medical prevention and not on environmental causes of breast cancer. Miriam
Hidalgo (interview November 30, 2010) also discussed the connection between
corporate pink products and the effects on the consumer and breast cancer
funding:
Buying a product makes people feel better momentarily. People donʼt
realize that they need to ask questions about where is the money going,
how much of the money is going somewhere. What happens after
October? (A4) Does the company still make a profit or do they continue
to donate the money?
The EBCM not only argues that money from corporate sponsorship goes
to research and advocacy that is in line with mainstream prevention, but also
contends that not all of the money goes to actual prevention programs. Only a
portion of proceeds go to programs sponsored by corporations, and often
corporations profit from any extra money they receive in excess of what they
promised to give. The BCA created the Think Before You Pink campaign in 1992
to address the over-saturation of corporate pink products that flood the consumer
market, particularly during the month of October. The Think Before You Pink
campaign “calls for more transparency and accountability by companies that take
part in breast cancer fundraising, and encourages consumers to ask critical
questions about pink ribbon promotions” (Think Before You Pink 2011a).
According to the BCA, holding corporations accountable in their fundraising
practices is a way to reduce corporate profit from fundraising and keep
corporations from funding research that only serves their agenda. The BCA uses
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the power of consumer choice to demonstrate how the lay community can come
together and challenge the role of corporations in perpetuating and shaping
mainstream narrative of breast cancer prevention.

4.3: The Precautionary Principle and the Burden of Proof
One way the EBCM reframes breast cancer risk and prevention is through
the precautionary principle. According to Breast Cancer Action, taking a
precautionary approach to breast cancer risk is about “shifting the burden of
proof so that the companies that make and profit from products and activities
must prove that they are safe, rather than the current situation where the public is
required to prove that something is harmful before itʼs stopped” (Breast Cancer
Action 2008a). Instead of waiting until chemicals have already been linked to
causing cancer, Breast Cancer Action advocates that producers of chemicals
need to prove their safety before using them. If companies cannot prove that
chemicals are safe or there is reason to think that certain chemicals are not safe,
those chemicals should be regulated. Susan Fenton argues that proving the
harm of chemicals should not be the responsibility of individuals but there should
be an “increased government regulatory and industry responsibility” in ensuring
the safety of chemicals before they are used in consumer products (The
Collaborative of Health and the Environment 2011a). The Breast Cancer Fund
argues that a more precautionary approach to chemicals is needed because
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“more than 90 percent” of chemicals used in the United States “have never been
tested for their effects on human health” (Gray et al 2010:14). Since most
chemicals that are used by companies have not been proven to be safe, the
EBCM argues that they pose a health risk to communities and consumers. The
precautionary principle is a tool that environmental breast cancer activists like the
Collaborative on Health and the Environmentʼs (CHE) Breast Cancer Working
Group use to make the public and scientific community aware of the potential
harm of using certain chemicals. These activists also use the precautionary
principle to point out the challenge of scientific uncertainty in linking certain
chemicals to breast cancer, and the need to take action towards regulating
chemicals despite the uncertainty (The Collaborative for Health and the
Environment 2012a).
CHE activists use the precautionary principle not only to challenge
conventional science, but also to challenge government legislation to regulate
toxic chemicals. The precautionary principle “encourages close scrutiny of all
aspects of science, from the research agenda to the funding, design,
interpretation, and limits of studies, for potential impacts on the earth and its
inhabitants” (The Collaborative for Health and the Environment 2012a). CHE
uses the precautionary principle to advocate for equality in breast cancer
prevention. EBCM organizations like BCA advocate the precautionary principle
as way to eliminate injustice linked to environmental causes of breast cancer.
BCA urges that:
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With the health and lives of so many at stake, we must adopt a public
health approach — a precautionary principle — making policy changes
based on the weight of the evidence. Such a principle was used in policy
changes regarding the dangers of smoking, even though the precise
mechanism of cancer causation has never been scientifically explained.
BCA collaborates with individuals from organizations such as Physicians for
Social Responsibility, National Latina Institute for Reproductive Health, and
Womenʼs Cancer Action (Breast Cancer Action 2012) which are committed to
similar goals in order to achieve their political and scientific advocacy.
Miriam Hidalgo (interview, November 30, 2010) advocates for “shifting the
burden of proof” in terms of their legislative advocacy. An example of the Breast
Cancer Fundʼs work to incorporate a precautionary approach into legislation can
be seen in the 2003 adoption of the precautionary principle by the city of San
Francisco Board of Supervisors (Breast Cancer Fund 2011d). The adoption of
the legislation demonstrates the role of activists and community leaders in
challenging traditional legislation for one in which favors a precautionary
approach. Through collaborating with legislative leaders, Breast Cancer Fund
activists helped to get precautionary principle legislation passed in San
Francisco. Activists view the passing of legislation as a major victory for their
precautionary principle efforts, not only because of the overwhelming majority
vote in favor of the legislation (A5), but also because the “ordinance reorganized
11 separate pieces of environmental legislation into one environmental code with
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a visionary precautionary principle policy statement serving as its first
chapter” (Breast Cancer Fund 2011d).
The precautionary principle represents the EBCMʼs reframing of risk and
risk management from focusing on the individual to focusing on environmental
factors that put communities and populations at risk for breast cancer. CHE
advocates the precautionary principle as a form of environmental justice that
holds producers of chemicals accountable in order to protect communities from
exposure to toxic chemicals. According to Richard Clapp, precautionary
approaches are a matter of ethics and already exist in fields like public health
(The Collaborative for Health and the Environment 2011a):
I just want to emphasis that the public health community...has what they
call principles for public health practitioners. One of those principles is
essentially a statement that in the absence of complete knowledge of
mechanisms and perhaps complete knowledge of all who might be
exposed to some agent that might cause disease. We ought to take a
precautionary approach and we ought to do it as a matter of principle. Itʼs
an ethical call by the main public health organizations in this country to act
when we have reasonable knowledge about the mechanisms of harm
arenʼt fully known.
The precautionary principle also gives the lay community transparency in science
and legislative decisions, and thus shifts power from dominant science and
government institutions to the lay community (Gray et al 2010).
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4.4: Citizen Science and Scientific Transparency
Through citizen science, the EBCM seeks to reframe dominant power
structure in order to create transparency and democratic decision making in the
lay community. The Long Island Breast Cancer Center Project is an example of
how citizen science reshapes the power dynamic found in mainstream breast
cancer research. The goal of the Long Island Breast Cancer Center Project was
to encourage the advocacy and research community to discuss the disparities
and limitations in breast cancer research (Karen Miller, interview, December 2,
2010). Through the Long Island Breast Cancer Center project, breast cancer
advocates, research scientists, and political leaders realized the redundancies
and gaps in breast cancer advocacy. They also realized that more collaboration
was needed to fix the gaps and redundancies that existed in breast cancer
research and programs. According to Karen Miller “there is still this type of
tremendous push to work in a silo...to not trust..to be very competitive” (interview,
December 2, 2010). The NBCC uses citizen science to tear down the silos that
exist among science, political and advocacy communities through
comprehensive collaboration with all three communities, as well as full
transparency to the public.
Another example of citizen science can be found in NBCCʼs Project LEAD
programs. Through Project LEAD, the NBCC offers classes, workshops and
seminars “teaching about the science behind breast cancer” (Kathryn Johnson,
interview, December 7, 2010). The goal of Project LEAD is to empower the
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public by giving them the scientific information to become citizen scientists in
their own communities. While the biomedical community as a whole may not be
receptive to citizen science, Project LEAD is an example of how critical
epidemiologists (Brown 2007:37) support citizen science through educating the
lay community about the science involved in breast cancer research. Graduates
of Project LEAD can take the scientific information they learn and apply it to their
communities to create research and advocacy that reflects the communitiesʼ
experiences of breast cancer. After completing the program, graduates are not
only able to team with scientists and present their findings at scientific
conferences, but they are also able to “serve on decision-making boards of local,
state and national organizations, committees and Institutional Review
Boards” (National Breast Cancer Coalition 2011e). Through programs like
Project LEAD, NBCC provides the lay community with the scientific knowledge
needed to actively engage with the scientific community and participate in the
scientific decision making process. Providing this scientific knowledge allows
activists the ability incorporate lay knowledge into scientific decision making
process.
A third example of citizen science can be seen in NBCCʼs 2020 campaign.
The 2020 campaign is focused on ending “breast cancer by the year 2020 by
bringing the beast research and public policy minds together to bring as current
information as there is about breast cancer” (Kathryn Johnson, interview,
December 7, 2010). The NBCC teams activists with scientific and political
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leaders to work collaboratively on ending breast cancer by 2020 (National Breast
Cancer Coalition 2010). According to the NBCC, “the information and the
science and the research and the medical knowledge is out there,” and setting a
deadline “presses the issue and focuses the attention” on ending breast cancer
(Kathryn Johnson, interview, December 7, 2010).
Like other EBCM organizations, the NBCC contests conventional science
and policyʼs silo mentality that prevents them from actively collaborating with
each other and the lay community. By removing the silo mentality through
collaboration with science, policy and lay communities, the 2020 deadline
illustrates the EBCMʼs reframing of a dominant power structure that keeps
knowledge within its respective spheres and does not put value on lay knowledge
of breast cancer (Benford and Hunt 2003:161). The 2020 deadline represents
citizen involvement in science because it not only focuses on collaborating with
science and policy leaders, but it also represents citizen scienceʼs call to focus
on ending breast cancer rather than treating the disease.
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CHAPTER 5: DISCUSSION

5.1: Contesting Risk
The EBCM contests the mainstream narrative of risk found in dominant
science research and advocacy. The mainstream narrative of risk focus on how
individuals are at risk for breast cancer. The National Cancer Instituteʼs
information on breast cancer risk factors demonstrates how the mainstream
breast cancer movement views risk through individual factors such as genetics
and family history (National Cancer Institute at the National Institutes of Health
2010). On the other hand, the EBCM argues that risk occurs on a population
level and is more complex than the mainstream narrative suggests because of
the interplay between various chemical toxins and social inequalities on
communities. The EBCM contests dominant focus on genetic and family risk
because the EBCM argues that there is a complex interplay of environmental
toxins on communities and populations. Looking at risk on a population level
gives a broader and more accurate view of risk. According to the EBCM, risk not
only affects communities but social disparities also affect how different
communities experience breast cancer risk. Social inequalities influence risk
because poor and ethnic communities are exposed to more and more varied
chemical toxins, thus increasing their breast cancer risk. Understanding how risk
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affects communities and how toxins play into community risk is key to reducing
breast cancer.
By contesting individual risk, the EBCM seeks to challenge the way the
mainstream causation narrative affects how breast cancer is viewed and treated.
Susan G. Komen, a mainstream breast cancer organization, claims that “knowing
the basic types of risk can help you understand your chances of getting breast
cancer and the steps you can take to lower your risk” (Susan G. Komen for the
Cure 2012b). However, the EBCM calls for a different way to examine risk
because they claim that the dominant narrative of risk does not adequately
address the larger and more complex framework of breast cancer risk.
Environmental breast cancer organizations like CHE look at community risk
because they argue that it more adequately addresses the complex nature of
chemical exposure and social inequalities that dictate breast cancer risk (The
Collaborative of Health and the Environment 2012b). The varied narrative of
breast cancer risk by the mainstream and environmental activists represents
different “perspectives” and “purposes” in defining breast cancer as a social
problem (Bash 1995:27). The purpose in defining risk on a population level
verses an individual level illustrates the EBCMʼs assertion that social factors
influences breast cancer risk. Redefining risk also represents the different
perspective of how risk plays into larger the framework of the breast cancer
narrative. Focusing on individual risk obscures the larger environmental and
social connections that are found when looking at risk at a population level. The
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larger framework of risk helps to explain why a larger portion of women get
breast cancer and offers a more dynamic solution to the complexity of breast
cancer risk.
The assertion of risk at a population level is significant because it
illustrates the contested nature of breast cancer and how power dynamics
influence risk narrative. Like other contested illnesses, breast cancer has a
dominant narrative that influences perceptions of breast cancer risk.
Contested illnesses such as asthma (Senier et. al. 2011:171) and learning
disabilities (Davis 2007:417) all have a dominant narrative that obscures the
environmental narrative from gaining legitimacy in a public arena. With the
increase of illnesses like “cancer, asthma, heart disease, birth defects,
developmental disabilities, diabetes, endometriosis, infertility, and Parkinsonʼs
disease,” collaborative groups like CHE are using scientific research to show the
increasing connection to “chemical contaminants as contributing to the growing
toll of human suffering” (The Collaborative of Health and the Environment
2012b).
EBCM activists are part of a larger network of advocates for the
recognition of environmental causes of certain illnesses. According to Marisa
Walker (interview, December 10, 2010):
Itʼs not just about breast cancer. Obviously we are breast cancer focused.
Many of the chemicals we talk about are linked to other diseases and
cancers, Parkinson's, learning disabilities, fertility problems. We work with
organizations that represent all of those interests and together itʼs very
compelling and very powerful.
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EBCM movement activists work with other contested illness activists in order to
strengthen their argument. By coming together, they are creating a network of
contested illnesses and are able to draw on research done about other
contested illnesses. Collaborating also allows a stronger argument for
environmental connections to illness since more illnesses and activists are
involved.
The EBCM seeks a different narrative of breast cancer risk and as a result
it challenges the dominant narrative (Blumer 1971:303; Button 2010). By offering
an alternative narrative, the EBCM must contend with the credibility that the
mainstream has built as the dominant narrative. The “hierarchy of
credibility” (Loske 1999:35) exists in the favor of dominant narrative because
mainstream science and advocacy favor individual risk. The EBCM must
contend with the dominant narrativeʼs power in mainstream science and
advocacy surrounding risk. The dominant narrative represents authoritative
knowledge, and as such this “one body of knowledge is privileged over other
bodies in that it has greater access to ultimate reality or the ʻtruthʼ” (Malinowski
1922:177). As a result of the dominant narrativeʼs construction of truth, “rational
organizations and human beings are expected to organize their conduct to reflect
this truth” (Kroll-Smith and Floyd 2000:85). Rational knowledge “is always a
legitimating idea” (Wright 1992:6) on which the reality of an issue like breast
cancer is based (Lyotard 1992: 29). The EBCM uses scientific knowledge and
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collaborations with scientists that favor critical epidemiology to create a space for
lay knowledge within the realm of breast cancer research. Organizations like the
National Institutes of Environmental Health Sciences (Brown 2007:36)
collaborate with citizen scientists in order to reconstruct conventional biomedical
methods.

5.2: Contesting Dominant Risk Management
The EBCM also contests the dominant focus on prevention through
technology and pharmaceuticals. The dominant narrative of breast cancer
prevention focuses on mammography and pharmaceuticals like tamoxifen to
reduce breast cancer risk. Susan G. Komen, a mainstream breast cancer
organization, argues that prevention is actually “risk reduction” because they
argue that true prevention is not possible (Susan G. Komen for the Cure 2011):
People who brush their teeth can still get cavities. And, people who always
wear their seat belts may still get hurt in a car crash. We do what we can
to improve the chances of a good outcome, but we don't always have
complete control. When talking about cancer and other chronic diseases,
the same concept applies. Prevention mainly refers to lowering the risk of
getting a disease rather than completely removing the risk.
EBCM activists contest mainstreamʼs assertion that reducing risk is an
adequate form of breast cancer prevention. According to the EBCM,
mammography and tamoxifen are not true prevention because they are only
useful for detecting and treating cancer that already exists or, in the case of
tamoxifen, it is also prescribed for women who are at a high risk for developing
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breast cancer. The Breast Cancer Fund argues that mainstream prevention
methods are not adequate and advocates “moving away from blanket guidelines
and toward an investment in safer and more effective alternatives and a better
understanding the causes of the disease” (Inside Prevention: Breast Cancer
Fund Blog 2009). The EBCM asserts that true prevention must happen before a
woman gets breast cancer. According to Karen Miller, President and Founder of
Prevention is the Cure, ““There is no cure for disease. There is no immediate
magic bullet for disease. Prevention can be the ultimate cure. It takes all of us
understanding how we can be apart of this process and really lower the risk for
disease” (Blip 2012). Groups like Prevention is the Cure advocate for
environmental prevention of toxic chemicals and provide the lay community with
the scientific knowledge to empower them to be part of the process of
environmental prevention advocacy. The contestation of the mainstream
narrative of risk also challenges the role of corporate funding in shaping science
and legislation related to risk management because it empowers the lay
community to challenge corporate interest when advocating for environmental
prevention. Citizen science allows lay experience of breast cancer science and
legislation to have an impact on future breast cancer advocacy. Though the
public paradigm, lay women are able to bring their experiences with breast
cancer into the larger breast cancer narrative and influence science and
legislative decisions related to their illness.
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The contestation of mainstream views of prevention by the EBCM
connects with a broader theme of contesting science as expert knowledge.
Since mainstream prevention narrative favors medical technology and
pharmaceuticals, science is placed in a higher authority when it comes to
methods of prevention. According to BCA Resource Liaison Zoe Christopher,
“there are no effective means for truly early detection of breast cancer” and “even
if you get a positive result, there currently isnʼt anything you can do to be more
vigilant about breast cancer than what you are already doing” (Breast Cancer
Action 2011c). Despite the EBCM assertion that medical breast cancer
prevention is not true prevention, the dominant narrative looks to science for
prevention because it has an authoritative voice in society and it is linked in the
public consciousness with life saving treatments for women who have been
diagnosed with breast cancer. Scientific knowledge is placed at a higher
authority because society values “the language of biomedicine” in understanding
disease cause and prevention (Kroll-Smith and Floyd 2000:85). Since
biomedical models of prevention are favored by the dominant narrative, any other
view of prevention is viewed as challenging the dominant narrative and is kept
out of the dominant breast cancer narrative. Nancy Evans describes the
importance of understanding and utilizing biomedical knowledge in advocacy
(The Collaborative of Health and the Environment 2006) :
Those of us in the advocacy community realize that understanding the
science of breast cancer including the statistics is what gives us credibility,
not only with scientists but with the public. Getting the numbers right
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when we are talking about the rising incidence of breast cancer over time
is particularly important in establishing environmental links to breast
cancer in a changing world.
Not only does The Collaborative of Health and the Environment use biomedical
knowledge to understand breast cancer risk, but they also advocate the methods
of analyzing breast cancer data should be reassessed. Making sure that the
data is understood correctly is an important element in understanding breast
cancer risk and prevention.
The EBCMʼs contestation of dominant prevention narrative acts as a
“practical epistemology” (Geertz 1983:151) in that it “joins the world of personal
and biographical experience to forms of instrumental rationality” (Kroll-Smith and
Floyd 2000:85). Because the EBCM includes the personal narratives of the lay
community in its argument for prevention, the dominant narrative does not view
the EBCMʼs narrative on prevention as valid. Although the mainstream narrative
provides methods to help women understand risk and treatment methods, both
the lay and certain individuals within the scientific expert community realize that
more needs to be done in order to stop women from getting the disease.
Environmental activists see the degradation of their environment and how it
impacts their health and the health of their communities. These experiences and
observations serve as a basis for their activism in the EBCM. Although the public
did not know about her breast cancer diagnosis at the time of the publication of
her book Silent Spring (Silent Spring Institute 2012) , her activism inspired the lay
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community to educate themselves about the science related to environmental
links to breast cancer. In Sabrina McCormickʼs (2007) book No Family History:
The Environmental Links to Breast Cancer, she mentions womenʼs experiences
with breast cancer and how these experiences lead them to environmental
activism. One example McCormick mentions how Barbara Balaban (McCormick
2007:91), who herself did not have breast cancer, realized that women in her
Long Island community were getting breast cancer and worked with the scientific
community to understand the cancer clusters in her community. The experience
of Rachel Carson as well as women like Barbara Balabon illustrate how personal
narratives reflect a desire to understand the environmental links to breast cancer.
Despite this personal narrative found in the EBCM, the mainstream tries to
“exclude public knowledge” in order to maintain what the dominant narrative
views as a “pure” knowledge found in traditional scientific knowledge (Tsing 2005
also cited in Button 2009:167). Breast Cancer Actionʼs webpage on Pills for
Prevention articulates the differing views of prevention and how prescriptions fit
into the dominant narrative of prevention (Breast Cancer Action 2008b):
The prevention of breast cancer is the ultimate goal of most people
involved in breast cancer work: from activists, to doctors, to research
scientists. There is far less agreement, however, about how to achieve
that goal. For many people in the medical and scientific community, the
answer lies in finding pills that will protect people against the disease. For
Breast Cancer Action and many womenʼs health activists, the acceptable
approach to breast cancer prevention lies in putting the publicʼs health
before private profit, which involves finding and eradicating the causes of
breast cancer instead of medicating healthy women.
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Breast Cancer Action not only argues that pharmaceuticals are not an
adequate form of breast cancer prevention, but that pharmaceutical companies
are profiting from medical prevention. EBCM organizations like Breast Cancer
Action argue against pharmaceutical companies profiting from prevention
because it gives these companies an incentive to perpetuate medical prevention
as well as a way to distract public attention from their role in producing chemicals
linked to illnesses. Similarly to contested illnesses like endometriosis (Capek
2000:356), environmental breast cancer activists also contest pharmaceutical
funding because some of the same pharmaceutical companies that want to
provide funding are producing chemicals that are linked to that same illness.
Environmental breast cancer activists cite Astra-Zeneca is an example of a
pharmacutical company that funds breast cancer research while producing
chemicals linked to the disease. Because pharmaceutical companies are tied in
with major scientific research, they are in a position to shape breast cancer
research and to undermine other research that contests medical prevention
methods.
Since pharmaceutical companies are tied in to dominant science, they are
part of the hegemony which “asserts the economic and political interests of some
while simultaneously ʻmystifyingʼ this essential inequality in power-relations for
others” (Malinowski 1922:179). Pharmaceutical companies are hegemonic
because they uphold the interest of medical prevention while keeping knowledge
contesting medical prevention out of the mainstream breast cancer narrative.
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Organizations like Breast Cancer Action realize that since pharmaceutical
companies are tied in with dominant science, accepting funding from
pharmaceutical companies would bias Breast Cancer Actionʼs advocacy. Since
BCA focuses on “providing unbiased information,” it does not take money from
corporations that manufacture harmful chemicals, or from pharmaceutical
companies or health insurance organizations (Breast Cancer Action 2011d).
Karen Miller (interview, December 2, 2010) from the National Breast
Cancer Coalition describes the concern of becoming biased through
pharmaceutical funding:
Certainly if I am to talk about Gentech or AstraZeneca, … each one of
those pharma industries contacts our organization, as well as other
organizations, and they say we have funding for you. We donʼt want to
be associated or when we look at the fine print they have some control
over what you can and cannot say.
Organizations like the National Breast Cancer Coalition do not accept money
from pharmaceutical companies like Gentech or AstraZeneca because they have
funding stipulations would give them the power to shape the organizationʼs
breast cancer narrative, as well as methods for cure and prevention (Hyatt
1997:234). Pharmaceutical companies control “the production of truth” (Foucault
1980:133) in terms of the breast cancer prevention narrative through their
funding of science and organizations that are in line with their breast cancer
narrative. Organizations like Breast Cancer Action and National Breast Cancer
Coalition realize that if they accept money from pharmaceutical companies, their
organizations would end up becoming tools to continue a pharmaceutical-
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friendly narrative and would compromise their environmental prevention
advocacy.

5.3: Reframing Risk Through the Precautionary Principle
The precautionary principle is a method that the EBCM uses to contest
dominant paradigmʼs focus on personal risk. The EBCM uses the precautionary
principle to deal with the complexity and uncertainty of environmental risk that is
the source of its contestation in the larger breast cancer narrative. CHE argues
that contested illnesses like “breast cancer and other cancers result from a
complex web of causation” that not only includes environmental toxins but the
effect of social inequalities as well (The Collaborative of Health and the
Environment 2012b). The EBCM uses the precautionary principle to illustrate that
looking at the source of risk is important to ending breast cancer. Looking
upstream not only shows the cause, but it also illustrates how communities are
impacted by chemical exposure. The precautionary principle is used to “shift the
burden of proof to the chemical manufacturers” (Colborn et. al. 1996:219). The
precautionary principle makes producers of chemicals accountable for safety
instead of waiting until toxins effect communities. Since the precautionary
principle advocates for regulating chemicals despite the inability to definitely
prove their harm, uncertainty becomes a benchmark for further analysis of the
potential harm of chemicals.
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The precautionary principle serves as a public paradigm (Brown 2007)
that offers contested illnesses like breast cancer a way to reframe science and
advocacy to serve the public interest rather than the traditional paradigm that
serves private or corporate interest. As a public paradigm, the precautionary
principle “seeks to transform large and multifaceted aspects of social belief” and
“synthesizes the concerns of diverse social sectors: environmental policy, health
policy, economic planning and development, transportation, community planning
and development, international treaties, protocols, cooperation, and the general
democratization of society” (Mayer et. al 2002:576). The precautionary principle
reframes power relations among the lay community, the science community, and
the legislative community to provide the lay community with more equal voice in
the research and regulation of toxic chemicals. The Breast Cancer Fundʼs
“prevention is power” slogan resonates the message of empowerment through
prevention when it calls for the lay community to “take action to demand safer
products from companies and smarter laws from elected officials” (Breast Cancer
Fund 2011e). This message of empowerment is particularly important in
contested illness narratives like breast cancer because non dominant groups
must reframe the expert power dynamic of the dominant paradigm in order to
change the way science and legislation deals with toxic chemicals and chemical
regulation.
In terms of contested narratives, the precautionary principle serves as a
way for communities to contest the unequal power dynamic in society that allows
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manufactures of toxic chemicals to not only use chemicals with little regulation
(Ley 2009), but also lobby against regulation. Contested illnesses use the public
paradigm to claim that there is a social problem (Benford and Hunt 2003:160) in
terms of the power dynamic in chemical regulation. The precautionary principle
is used in contested illnesses as a way to assert a public paradigm that holds
chemical producers responsible for safety, and allows communities to actively
engage science and government to hold chemical manufacturers responsible for
the safety of their products. Contested illness narratives reframe the way society
looks at an issue and defines it as a social problem (Troyer and Markle 1984). In
the case of breast cancer, the precautionary principle reframes the way the
dominant narrative rests the burden of proof on communities and populations
rather than on the manufacturers of toxic chemicals.
For example, illnesses like asthma (Brown 2007:100) are often contested
by the dominant narrative of the illness as unable to definitively prove
environmental causation. The use of scientific uncertainty by the dominant
narrative provides scientists, policymakers, and others working within this
narrative with a way to “cast doubt on their critics and seek to undermine
challenges to the official narrative” (Button 2010:13) in order to maintain power
over the illness narrative. On the other hand, “advocates for the precautionary
principle counter that science is always a continuum: one answer leads to
another question, which leads to another answer, and so on” (Shapiro 2007:12),
and therefore scientific uncertainty should not hinder research and regulation of
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chemicals that may be responsible for illnesses. Groups like CHE argue that
scientific uncertainty should encourage further scientific research rather than be
a reason to cast doubt on the validity of environmental connections to contested
illnesses. CHE claims that “research on environmental contributors to breast
cancer and other diseases should be aggressively expanded” because “breast
cancer is a symptom of a larger public health crisis that demands action by
society as a whole” (The Collaborative of Health and the Environment 2012b).
The precautionary principle offers a way for the lay community to contest the
need for certainty. The lay community is then able to use scientific uncertainty to
demand government regulation and scientific research of chemicals. The
precautionary principle allows the lay community to reframe scientific uncertainty
to contest the dominant paradigms control over the official illness narrative
(Button 2009:167).

5.4 Reframing Risk Management Through Citizen Science
Citizen science reframes the power dynamic in science through inclusion
of lay knowledge. The lay community works with critical epidemiologists in the
scientific community on science research and science decisions through
scientific collaborations and serving on advisory boards. Lay activists use citizen
science as a method to insert their experiences with breast cancer into the breast
cancer narrative. Citizen science challenges expert knowledge as the only valid
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form through incorporating lay knowledge along with scientific knowledge. Karen
Miller describes the importance of incorporating lay and scientific knowledge (Blip
2012):
One of the most important things I think is as science is providing us with
continuous information about the connections between environmental
triggers and disease, we need to have that translated and disseminated so
it has a positive health impact. There is a tremendous gap between
science and political and public health impact. I think the activist
community is trying to fill in those gaps.
Despite the exclusion of lay knowledge in conventional science, biomedical
models of knowledge are important to understanding the role of environmental
toxins in breast cancer risk. Instead of creating an entirely new model to include
lay narratives, the public paradigm uses citizen science as a way to restructure
the conventional science model to include lay knowledge. The lay community
becomes involved in science and science decisions by doing research and
analyzing how to use research findings. Citizen science is part of a larger public
paradigm (Brown 2007) in that it seeks greater transparency and democracy in
the scientific research process.
Part of the public paradigm in EBCM activism involves citizens actively
collaborating with the scientific community. The National Breast Cancer
Coalitionʼs Breast Cancer Deadline 2020 campaign is an example of how
activists use “strategic summits, catalytic workshops and collaborative efforts with
a multi-disciplinary and diverse group of stakeholders” to redefine breast cancer
science though citizen science: (National Breast Cancer Coalition 2011f)
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Thatʼs why the National Breast Cancer Coalitionʼs (NBCC) advocates...are
calling for an end to breast cancer by January 1, 2020—Breast Cancer
Deadline 2020®. This serious and strategic plan of action is creating a
paradigm shift in the breast cancer community to refocus resources and
efforts on the goal of ending breast cancer.
Citizen scientists use biomedical knowledge in scientific collaborations. Like
other contested illnesses, environmental breast cancer activists are using
biomedicine to challenge traditional power structures in science. By using
biomedical knowledge, environmental breast cancer activists are “challenging the
received wisdom about the body by linking their somatic disorders to rational
explanations borrowed from the professions of medicine” (Kroll-Smith and Floyd
2000:83). Biomedical knowledge gives legitimacy to citizen scientists since
biomedical knowledge is valued in the science community. Like other embodied
health movements (Morello-Frosch 2006), EBCM activists must collaborate with
the scientific community using biomedical knowledge in order to reshape the
power dynamic found in traditional science. Rather than refusing scientific
knowledge (Sagan 1996), activists are using “language of biomedicine” to
redefine research methods and discourses of power in the scientific community
(Kroll-Smith and Floyd 2000:83).
According to social problems literature, these activities articulate the
claims of a group, and therefore lay participation in citizen science illustrates the
EBCMʼs contestation of dominant science knowledge in undermining lay
knowledge (Spector and Kitsuse 1977). Collaborating with the scientific
community and acting on the results of collaborations are an important part of
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citizen science. Marisa Walker articulates how citizen science uses scientific
knowledge in their advocacy: “We then go and put it [scientific research] into
action. We put it into a solution to reduce exposure or to explore the chemical
further. So now [that] we have all the science, what are we going to do with it [is]
to turn it into solutions” (interview, December 10, 2010). According to the
National Breast Cancer Coalitionʼs State of the Evidence report, citizen science
offers “opportunities for citizen involvement in raising scientific questions and for
personal and civic responses to the resulting exposure data” (Gray et al
2010:31).
Julia Brody cites the lack of success in certain prevention programs in
minority communities as an example of the importance of including communities
in scientific advocacy (The Collaborative of Health and the Environment 2011b):
When you talk to the general public, particularly communities of color, they
do not want to talk about it, they donʼt know about it. Even the targeted
programs, whether it be for screening, many of these programs are put out
there but are not being used. So the excuse is we built it but they did not
come. I think what we need to start looking at is research that is more
community based so that communities can become involved in what the
problem is and once they buy the problem they will buy the solution.
This illustrates not only the potential of citizen science to enrich breast cancer
science, as a whole but it also shows how citizen science can empower
communities to seek environmental solutions that they view as important. Citizen
science not only allows for a more democratic process in research design, but it
also allows the lay community more control over how the research is translated
into further research and legislative decisions as well.
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An arenas approach illustrates that contested illnesses like breast cancer
exist as “a putative condition or situation that is labeled a problem in the arenas
of public discourse and action” through citizen science (Hilgartner and Bosk
1988: 55). According to the arenas approach, competition exists among groups
trying to define a particular social issue in different ways. Different or nuanced
definitions of a social problem are challenged in the public arena as the different
groups engage in a power struggle for the dominant social narrative of the
particular social problem (Hilgartner and Bosk 1988: 55). Power comes from a
groups definition of the social issue taken as the mainstream definition in the
public arena. By using biomedical models in scientific collaboration, EBCM
activists are able to gain validity in the public arena in order to get more research
and legislation for the environmental links to breast cancer. Much like other
contested illnesses, the MBCMʼs power comes from the adoption of the
mainstream narrative as the main narrative in breast cancer advocacy (Hilgartner
and Bosk 1988:55). Reframing science and the science decision process allows
the EBCM to gain legitimacy in the public arena and therefore diminish the power
of the dominant narrative in breast cancer discourse.
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CHAPTER 6: CONCLUSION
Like other contested illnesses, the EBCM activists challenge the dominant
breast cancer narrative through contesting and reframing (Benford and Hunt
2003:154) dominant narratives of risk and risk assessment. Dominant illness
narratives focus on individual risk and medical prevention methods. However,
EBCM organizations like the BCA realize that social and environmental factors
influence risk in their assertion that “creating awareness that not just genes, but
social injustices--political, economic, and racial inequalities--lead to disparities in
breast cancer outcomes” (Breast Cancer Action 2011e). Dominant illness
narratives also place legitimacy on expert knowledge in order to silence
alternative narratives (Button 2010:179). Through the implementation of a public
paradigm (Brown 2007:181), which promotes a precautionary approach and lay
involvement in the scientific process, EBCM activists contest the dominant breast
cancer narrative. The precautionary principle provides a way for activists to
demand research and regulation for chemicals linked to breast cancer despite
mainstream scienceʼs argument of uncertainty linked to proving. Citizen science
provides activists a way to reconstruct the power dynamic found in mainstream
biomedicine to include lay knowledge.
This chapter will address recommendations for future research and final
conclusions. In the first section, recommendations for future research will use
information and limitations discovered during the research process to bring up
areas for further investigation. The role of funding in mainstream breast cancer
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contestation, collaboration between environmental and mainstream groups and
the impact of geographic clustering on EBCM advocacy all offer potential for
future understandings of breast cancer as a contested illness. Lastly, this
chapter will conclude with final thoughts on the research and analysis.

6.1: Recommendations for Future Research
After analyzing the research conducted during the study, several
recommendations for future research became apparent. One area that warrants
future research is the EBCMʼs standpoint on the corporate funding of breast
cancer research and advocacy. Corporate funding represents the dominant
trend found in the mainstream breast cancer movement because it funds science
and advocacy programs that focus on individual risk in advocacy campaigns.
Corporate funding also supports medical prevention and research that focuses
on finding a medical cure for breast cancer. Medical prevention and cure
research is contested by EBCM activists, and therefore receiving corporate
funding contradicts the advocacy of the EBCM. Although some literature already
addresses the role of funding in breast cancer advocacy, more research and
literature is needed (King 2006:xxii), particularly to address the environmental
contestation of mainstream advocacy. Many of the people interviewed echoed
the concern that “accepting corporate funding can create a real or perceived
conflict of interest and undermine the credibility of an organization to reliability
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analyze and disseminate scientific information, especially data regarding clinical
trials for new drug protocols” (Frickel and Moore 2006:267). Marisa Walker
(interview, December 10, 2010) mentions that the Breast Cancer Fund does not
“take money from companies who make or sell toxic products” because that
would violate their environmental breast cancer advocacy and credibility in
advocating against toxic products in order to reduce the environmental risks
associated with breast cancer. Similarly, Karen Miller (interview, December 2,
2010) claims that National Breast Cancer Coalition would not take money from
pharmaceutical companies because it might undermine the organizationʼs ability
to run programs like their Crush and Flush Campaign. Funding represents an
important element in the contestation of the mainstream and warrants further
research.
Collaboration between environmental and mainstream breast cancer
organizations also requires further research. There is a varied level of
collaboration with the MBCM within the EBCM. Some organizations are opposed
to collaborating with mainstream breast cancer organizations because they do
not agree with mainstream involvement with corporate sponsors or the general
focus of their advocacy. Breast Cancer Actionʼs Think Before You Pink calls out
organizations like Susan G. Komen for the Cure and their collaboration with
sponsors on pink (Think Before You Pink 2011b). Also, Karen Miller (interview,
December 2, 2010) of National Breast Cancer Coalition argues that “most of the
large organizations are looking heavily...the majority of their money and their
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interest...is on treatment and screening” and this direction is not in line with
National Breast Cancer Coalitionʼs advocacy on prevention through elimination of
environmental toxins. Other environmental organizations like Silent Spring
Institute (2007) are more willing to partner with mainstream groups in their
advocacy programs. Research on the dynamic within EBCM towards
collaboration with MBCM would lend to the understanding of the variation of the
EBCM narrative and how that influences their advocacy.
The geographic clustering of EBCM organizations also requires future
research. Most EBCM organizations are located in the Northeast and California.
While some research facilities that the EBCM collaborates with were located in
areas other than those specified above, the location of the actual organizations
are found in the Northeast and California. Part of the reason for the geographic
clustering stems from higher rates of breast cancer found in New England and
California. Organizations like National Breast Cancer Coalition and Silent Spring
Institute started when women realized that there was a high percentage of
women getting breast cancer. Although these particular geographic areas have
seen significant effects of toxic chemicals in local communities, environmental
advocacy has implications for chemicals used nationwide. Future research
needs to examine the social and political reasons for the geographic clustering
and how it affects the EBCMʼs national advocacy. Research should also include
an analysis of environmental breast cancer advocacy in areas with no such
breast cancer organizations, like the Midwest and the South. There are also
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nuances in the narratives in Eastern verses Western organizations.
Organizations located in California, like the Breast Cancer Fund focus more on
ethnic and socioeconomic factors linked to breast cancer risk than organizations
located in New England, like National Breast Cancer Coalition. Understanding
the nuances in the regional narratives found within the EBCM is an important
area for future research. Analyzing the nuances in regional narratives will
illustrate how regional politics and social understandings breast cancer influence
the larger environmental breast cancer movement. The geographic nuances in
the environmental breast cancer illness narrative provide a dynamic look at how
local social networks influence illness narratives on a national scale.

6.2: Final Conclusions
After collecting and analyzing the research used in the study, three main
conclusions have been formed. The first conclusion is that the EBCMʼs
contestation of the dominant breast cancer narrative represents a wider pattern
of the use of alternative narratives use to contest dominant illness narratives. In
terms of contested illness, the EBCM represents the way alternative narratives
can challenge dominant illness narratives through the public paradigm (Brown
2007:181). The precautionary principle and citizen science provide advocates for
alternative narratives with methods to reconstruct forms of legitimacy used by
dominant narratives to assert their dominance over illness narratives. Michael
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Foucault “argued that expert knowledge about human ʻnormalityʼ and
ʻabnormality,ʼ which is not objective or naturally given, is the principal form of
power in modern societies” (Conrad and Barker 2010:S69). Dominant narratives
assert their dominance in society by undermining the legitimacy of other
narratives. The public paradigm offers a way for alternate narratives to assert
their legitimacy in order to contest the dominant narrative and the power it has
over the illness narrative. Despite the contestation of social knowledge by
mainstream narratives, science operates on “strong objectivity” (Harding
1991:142) which means understanding that the fact that “all knowledge, including
scientific knowledge, is rooted in social constructs does not negate the idea of
objectivity in the sense of fairness, justice, and intellectual honesty” (Wing
2000:40). The public paradigm not only represents a way for alternate illness
narratives to gain legitimacy, but it also enables the inclusion of social
transparency and equality in scientific research.
Drawing from and collaborating with advocacy groups focused on other
contested illnesses (Karen Miller, interview, December 2, 2010; Brown 2007:278)
offers another way for EBCM activists to contest dominant narratives and build a
network of scientific credibility to establish the environmental links to illnesses.
Advocates for contested illnesses argue that causation is a part of a wider
framework of social and environmental factors. Different contested illnesses find
common ground in the complex framework of causation. This illustrates how
social and environmental factors contribute to the causation of multiple illnesses.
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Advocates for contested illnesses like cancer and asthma (Lockwood et al
2009:3) argue that illness fits into a larger framework of environmental causation.
In terms of how breast cancer risk fits in to general cancer risk, Nancy Evans
argues that “It may be time to stop staying itʼs 1 in 8 or 1 in 9 and talk about
breast cancer in the larger context of cancer. The risk of which is now 1 in 3 for
women and 1 in 2 for men.” (The Collaborative of Health and the Environment
2006).
Alternate illness narratives argue that contested illnesses not only fit into a
larger environmental context, but they also fit into a social context in which
dominant illness narratives vie for control of illness narratives. The dominant
illness narrativeʼs “legitimization and reproduction of power” (Button 2006:432)
within the dominant hegemony creates a struggle for alternate narratives to have
their knowledge of illness causation viewed as valid by scientific and legislative
communities. While the “underlying cultural logic of mainstream narratives tends
to reinforce the hegemonic forces of our society,” (Button 2006:438) alternative
narratives collaborate through the public paradigm to not only challenge
mainstream narratives, but also the hegemony that contributes to the social and
power inequalities that keep communities at risk for illness.
The EBCMʼs adoption of the public paradigm also represents how the
challenge to dominant science by alternative narratives, through community
knowledge, can reconstruct credibility traditionally placed on expert knowledge
(Button 2010:13). The public paradigm represents a way for lay activists to
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challenge the authority of expert knowledge in defining social problems.
Embodied health movements like the EBCM are an important example of lay
contestation of the importance placed on expert knowledge. The contestations of
expert knowledge in embodied health movements “serve as a critical counterauthority aimed at democratizing and reshaping social policy and regulation in a
way that transforms the socioeconomic and political conditions that underline
unequal distributions of health and disease in the United States” (Morello-Frosch
et al 2006:267). Embodied health movements demonstrate how lay knowledge
can be legitimized through lay collaboration with the scientific and legislative
communities. Equality in research and decisions offers the lay community a way
to add to scientific knowledge and how it is used. Since expert knowledge
focuses on the technical aspects of a social problem, lay knowledge brings a
community perspective into the research and decision making process because
lay knowledge represents how communities view a problem and possible
solutions.
Connected with the public paradigm, community-based participatory
research (CBPR) offers the lay community a way to reconstruct the power placed
on expert knowledge by putting lay knowledge into science and legislation. The
National Breast Cancer Coalitionʼs Project LEAD (National Breast Cancer
Coalition 2011g) and The Long Island Breast Cancer Study Project are both
examples of how CBPRʼs reframe expert knowledge to include lay knowledge.
Although value is placed on expert knowledge, lay communities do not always
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think expert knowledge is adequately addressing their problem. CBPR offers a
way for communities to reshape scientific knowledge to incorporate lay
perspectives (Baralt and McCormick 2010:1669). Lay perspectives reflect
community knowledge and experience. Through CBPR, lay activists are able to
have a say in research design and their involvement in the research process.
The collaboration in research decisions and the goal of the research process aids
in “establishing mutual trust and cooperation between advocates and
scientists” (Baralt and McCormick 2010:1669-1770;Baker et al. 1999).
Educating the community about the science related to the health issue
they seek to address is another way CBPR contests expert knowledge (Baralt
and McCormick 2010:1770). By educating the community, CBPR aids in the
equality of power between lay and expert because the lay community is armed
with the biomedical knowledge to include lay knowledge in the research process.
Lay “experiences” and “perspectives” on the issue are incorporated into a
biomedical framework that aids in their collaboration with the science community
(Becker 1997). Once situated in a biomedical framework, lay narratives are
“empowering” because they “represent power and agency” that lay activists have
within the scientific process (Button 2006:432). Marisa Walker states that “We try
to propose solutions for people before they go to that place of being very fearful
which is a totally natural response to it. In that sense empowerment is very
important. We are trying to grow the understanding...” of biomedical knowledge
linked to breast cancer. CBPR exists within the larger context of the public
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paradigm in that it shifts power from expert communities to the general pubic.
CBPR offers lay activists a way to reconstruct (Bash 1995:11; Benford and Hunt
2003:161) traditional forms of knowledge within the larger public paradigm by
including lay knowledge alongside traditional forms of knowledge. Lay activists
can incorporate their knowledge to inform legislation and science to create
solutions that meet their needs rather than the interest of the dominant narrative.
Lastly, the public paradigm found in contested illness narratives, like
breast cancer, illustrates how paradigm shifts represent a pendulum of social
change. Due to environmental breast cancer advocacy, the scientific and
legislative community is increasingly incorporating the public paradigm into their
respective fields. As a part of the public paradigm, environmental justice
advocates to empower lay communities with knowledge and decision making
power related to environmental issues and as a part of the public paradigm it
“faces efforts to delegitimize it” (Capek 2000:357). Environmental justice,
including the EBCM, has helped to build the credibility of the public paradigm
among scientific and legislative communities. Environmental justice has helped
to gain this credibility through successful measures to “redirect federal research
dollars to support new scientific avenues of research that more purposefully
address how social context and economic inequalities impact public
health” (Morello-Frosch et al 2006:266; Morello-Frosch et al. 2002). The role of
environmental justice as a part of the public paradigm represents “institutional
shifts in medical science and public health [that] have helped nurture a new
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cadre of scientists who support activist efforts to democratize knowledge
production through their roles as program officers in federal funding agencies
and as researchers working collaboratively with EHM organizations to address
persistent challenges in disease treatment and prevention” (Morello-Frosch
2006:266). While the public paradigm is gaining momentum in scientific and
political spheres, it is still vulnerable to delegitimization by mainstream illness
narratives (Capek 2000:357).
Through continued advocacy, social movements like the EBCM are able to
tip the scales of social change towards their view of a solution to a social
problem. However, activists must realize that the pendulum of social change
depends on persistent advocacy. Karen Millerʼs (interview, December 2, 2010
warning represents the understanding of the pendulum of social change by social
activists:
My caution too is that at any moment for any reason when our heads our
turned on something else everything can go back. The pendulum can
swing and take us back ten years. Thatʼs what drives the activists and the
advocate community. You are going to find that everybody you are going
to talk to is going to be unbelievably articulate, passionate and totally
committed. This is definitely something that is driven by your heart and
not your head. If you were doing it from your head, you would not be
doing it.
The combination of desire and an immense knowledge of the social problem
drives the advocay community to create and maintain social change. The
inclusion of both emotion and logic contests expert knowledge that emphasizes
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the lens of logic. However, the combination of passion and knowledge are
essential in maintaining the balance of the pendulum of social change.
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A1: Tamoxifen is used as a treatment for early and late stage breast cancer
(National Cancer Institute at the National Institutes of Health 2008).
A2: Phone interviews were scheduled via e-mail and phone with individuals from
Breast Cancer Action (www.bcaction.org), National Breast Cancer Coalition
(www.breastcancerdeadline2020.org) and Breast Cancer Fund
(www.breastcancerfund.org). Zero Breast Cancer (www.zerobreastcancer.org)
and Silent Spring Institute (www.silentspring.org) were also contacted for
interviews via phone but did not contribute to the research.
A3: Exposure to bisphenol A (BPA) has been linked to “breast and prostate
cancer, and infertility (Environmental Working Group 2012).
A4: October was designated by Zenica (now AstraZeneca) to promote
awareness of breast cancer and prevention methods like mammography
(National Breast Cancer Awareness Month 2012). Organizations like Komen for
the Cure spend the month of October generating awareness and fundraising
efforts for breast cancer research.
A5: The first chapter of the San Francisco Precautionary Principle Resolution
mandates the use of the precautionary principle in San Francisco and requires
safer alternatives for products purchased for San Francisco city and county
(Taking Precaution.org 2004).

106

VITA
Amy Elizabeth Scanzillo was born in St. Louis, Missouri. Later, she
moved to Millington, Tennessee where she graduated from Millington Central
High School in 2004. After she received a Bachelor of Arts in Anthropology from
the University of Tennessee at Knoxville in May 2008, she attended graduate
school at the University of Tennessee. While pursuing a Masterʼs of
Anthropology at the University of Tennessee, she was a Teacherʼs Assistant for
Introduction to Cultural Anthropology. After graduation, she hopes to work for a
non-profit organization focusing on womenʼs reproductive health.

107

